US20050027182A1 - System for monitoring physiological characteristics - Google Patents

System for monitoring physiological characteristics Download PDF

Info

Publication number
US20050027182A1
US20050027182A1 US10/750,080 US75008003A US2005027182A1 US 20050027182 A1 US20050027182 A1 US 20050027182A1 US 75008003 A US75008003 A US 75008003A US 2005027182 A1 US2005027182 A1 US 2005027182A1
Authority
US
United States
Prior art keywords
alarm
physiological characteristic
condition
monitor
characteristic monitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/750,080
Other languages
English (en)
Inventor
Uzair Siddiqui
Himanshu Patel
John Mastrototaro
Linda Fredrickson
Kris Holtzclaw
Bruce Wenholz
Mark Estes
Frank Saidara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Minimed Inc
Original Assignee
Medtronic Minimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/034,139 external-priority patent/US7022072B2/en
Application filed by Medtronic Minimed Inc filed Critical Medtronic Minimed Inc
Priority to US10/750,080 priority Critical patent/US20050027182A1/en
Priority to US10/860,114 priority patent/US7399277B2/en
Assigned to MEDTRONIC MINIMED, INC. reassignment MEDTRONIC MINIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SIDDIQUI, UZAIR, ESTES, MARK C., SAIDARA, FRANK, FREDERICKSON, LINDA P., PATEL HIMANSHU P., WENHOLZ, BRUCE R., HOLTZCLAW, KRIS R., MASTROTOTARO, JOHN J.
Priority to DK04814197.2T priority patent/DK1703839T3/da
Priority to AT04814197T priority patent/ATE544394T1/de
Priority to EP04814197A priority patent/EP1703839B1/de
Priority to JP2006547123A priority patent/JP2007516783A/ja
Priority to CA2550855A priority patent/CA2550855C/en
Priority to PCT/US2004/041985 priority patent/WO2005065538A2/en
Publication of US20050027182A1 publication Critical patent/US20050027182A1/en
Priority to PCT/US2005/019106 priority patent/WO2005121785A2/en
Priority to CA2567711A priority patent/CA2567711C/en
Priority to US11/807,786 priority patent/US8961416B2/en
Priority to US14/599,010 priority patent/US10080529B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
    • A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
    • A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0443—Modular apparatus
    • A61B2560/045—Modular apparatus with a separable interface unit, e.g. for communication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms

Definitions

  • This invention relates generally to medical monitoring systems. More specifically, this invention relates to methods and systems for monitoring physiological characteristics in individuals including those associated with physiological conditions (e.g. monitoring blood glucose levels in diabetics).
  • a variety of electrochemical sensors have been developed for detecting and/or quantifying specific agents or compositions in a patient's blood.
  • glucose sensors have been developed for use in obtaining an indication of blood glucose levels in a diabetic patient. Such readings are useful in monitoring and/or adjusting a treatment program which typically includes the regular administration of insulin to the patient.
  • Periodic blood glucose readings significantly improve medical therapies using semi-automated medication infusion devices.
  • Some exemplary external infusion devices are described in U.S. Pat. Nos. 4,562,751, 4,678,408 and 4,685,903
  • some examples of automated implantable medication infusion devices are described in U.S. Pat. No. 4,573,994, all of which are herein incorporated by reference.
  • Electrochemical sensors can be used to obtain periodic measurements over an extended period of time.
  • Such sensors can include a plurality of exposed electrodes at one end for subcutaneous placement in contact with a user's interstitial fluid, blood, or the like.
  • a corresponding plurality of conductive contacts can be exposed at another end for convenient external electrical connection with a suitable monitoring device through a wire or cable.
  • Exemplary sensors are described in U.S. Pat. Nos. 5,299,571; 5,390,671; 5,391,250; 5,482,473; and 5,586,553, which are all incorporated by reference herein.
  • a glucose crash occurs when blood glucose levels of an individual are in a state of rapid decline and its symptoms are similar to those associated with hypoglycemia.
  • the symptoms are caused by the dynamics of a declining glucose level and not by an absolute glucose level.
  • Specific symptoms can include a feeling of light headedness, sweating, tremors, nervousness and/or disorientation. Disorientation is a particular risk to the patient. If the patient becomes disoriented while operating machinery, the patient could harm himself or others.
  • a glucose crash can be caused by any of the following events: excess insulin administration; an unexpected increase in insulin sensitivity; a fall of free fatty acids in the blood; heavy exercise; or mental or physical stress.
  • ordinary glucose monitors provide only for detection of hypoglycemic and hyperglycemic levels.
  • Impaired fasting glucose is another condition which is not predicted by conventional glucose monitors.
  • the American Diabetes Association (ADA) identifies IFG as an undesirable glucose condition, defined as a 126 mg/dL or higher blood glucose level at wakeup. Repeated IFG events can contribute to diabetic morbidity.
  • One cause of IFG is an inadequate nocturnal insulin basal infusion rate.
  • a patient can deal with the IFG after waking by administering an insulin bolus, it is preferable for the patient to avoid IFG incidents entirely.
  • Conventional monitors are designed to alert the user of unsafe conditions; however, many other factors and situations are also important to the user in managing treatment. For example, events such as meals or exercise, as well as entering calibration values are not tied to reminders issued by conventional monitors. Typical monitors provide only a single alarm to call attention to the user. This can be problematic in contexts of varying physiological states because a user is not made aware of the specific condition and/or the appropriate degree of urgency. In conventional alarm systems, until the user investigates, there is often no indication of the reason for the alarm or the severity of the situation.
  • the invention as embodied and disclosed herein pertains to apparatuses and methods for monitoring physiological characteristics such as blood glucose levels.
  • Embodiments of the invention include dynamic monitoring functions that can perform predictive analyses to anticipate harmful conditions, such as hyperglycemic (or hyperglycemic) incidents, before they occur. These dynamic functions can be used to monitor normal physiological functions, as well as in a variety of other contexts including the optimization of athletic performance.
  • Other embodiments of the invention include advanced alarm and reminder functions, as well as advanced data presentation tools.
  • Embodiments of the invention disclosed herein facilitate the convenient and efficient management of diseases such as diabetes.
  • One embodiment of the invention includes a method of monitoring a physiological characteristic of a user using a device including an input element capable of receiving a signal from a sensor that is based on a sensed physiological characteristic value of the user, and a processor for analyzing the received signal.
  • the processor determines a dynamic behavior of the physiological characteristic value and provides an observable indicator based upon the dynamic behavior of the physiological characteristic value so determined.
  • the physiological characteristic value is a measure of the concentration of blood glucose in the user.
  • the process of analyzing the received signal and determining a dynamic behavior includes repeatedly measuring the physiological characteristic value to obtain a series of physiological characteristic values to determine how the physiological characteristic is changing over time.
  • each of the series of physiological characteristic values includes a smoothing filtered group of repeated physiological characteristic value readings.
  • a slope of a line fit to the series of physiological characteristic values can be calculated if a most recent of the series of physiological characteristic values is within a qualifying range.
  • the physiological characteristic value readings may be decreasing and the slope is negative.
  • the indicator can also include a warning alarm that is responsive to the dynamic behavior profile of the physiological characteristic value.
  • the warning alarm can also announce an anticipated glucose crash or merely low glucose levels, depending on the operating parameters of the particular dynamic analysis, including comparison of the slope to a threshold rate (e.g., 1% to 3% per minute) and comparison of the current measured value to a qualifying range (e.g., 60 to 150 mg/dL).
  • a threshold rate e.g., 1% to 3% per minute
  • a qualifying range e.g., 60 to 150 mg/dL.
  • the series of values analyzed is taken from a defined span of time (e.g., ten to thirty minutes).
  • an anticipated physiological characteristic value is determined from an extrapolated curve based upon the series of physiological characteristic values.
  • the indicator can provide a warning of an anticipated morning glucose incident.
  • the series of values analyzed can also be taken from a defined span of time (e.g. one hour).
  • the extrapolated curve is determined from a slope of a line fit to the series of physiological characteristic values and an average of the series of physiological characteristic values.
  • the anticipated physiological characteristic value can be determined approximately three hours before an anticipated wakeup time.
  • the indicator can be provided if the anticipated value is outside a qualifying range (e.g., approximately 60 mg/dL to 126 mg/dL).
  • a slope of a line fit to the series of physiological characteristic values is calculated if a most recent of the series of physiological characteristic values exceeds a threshold value and the slope is positive.
  • the indicator can provide a warning of an anticipated hyperglycemic incident.
  • the series of physiological characteristic values spans a time period of approximately thirty minutes and the indicator will be provided if the slope is steeper than a threshold rate.
  • a typical threshold rate can be approximately 3% per minute and the threshold value can be approximately 180 mg/dL.
  • the indicator can provide a warning of an anticipated hypoglycemic incident.
  • the series of physiological characteristic values spans a time period of approximately thirty minutes and the indicator will be provided if the slope is steeper than a threshold rate.
  • a typical threshold rate can be approximately 3% per minute and the threshold value can be approximately 70 mg/dL.
  • a physiological characteristic monitor (and corresponding methods for its use) including an input device capable of receiving a signal from a sensor and a processor capable of analyzing the received signal and providing multiple alarms, each of which can be based upon different conditions associated with the physiological characteristic value of the user.
  • the signal is based on a physiological characteristic value of a user.
  • the multiple alarms are distinguishable from each other and can include any one of a wide variety of signals such as audible signals, visual signals, tactile signals, displays, and/or the like.
  • the processor determines a physiological characteristic value from the received signal and the multiple alarms are based upon that value. In such embodiments, each of the multiple alarms can then be triggered if the physiological characteristic value exceeds an associated threshold value.
  • one of a first pair of the multiple alarms can be triggered when a narrow range of physiological characteristic values is exceeded.
  • the first pair of the multiple alarms is typically associated with a first upper threshold value and a first lower threshold value, respectively.
  • a second pair of multiple alarms can be triggered by events a wide range of physiological characteristic values (e.g. exceeding a predetermined value).
  • the second pair of the multiple alarms can be associated with a second upper threshold value and a second lower threshold value, respectively.
  • a physiological characteristic monitoring method and device which include an input device capable of receiving a signal from a sensor and a processor for analyzing the received signal.
  • the signal is based on a physiological characteristic value of a user.
  • the processor initiates a timer based upon a condition associated with the physiological characteristic value of the user and provides a reminder to the user following expiration of the timer.
  • the reminder can include an alarm signal selected from the group consisting of an audible signal, a visual signal, a tactile signal, a display, and/or the like.
  • the duration of the timer is preset based upon the specific initiating condition.
  • conditions which trigger the one or more alarms can vary.
  • the conditions which trigger the one or more alarms can be an event marker such as meal markers, exercise markers, high blood glucose markers and low blood glucose markers.
  • the condition(s) which trigger the one or more alarms can further be a reference value that is entered into the monitor and the reminder can indicate that a new reference value should be entered.
  • the processor can determine a physiological characteristic value from the received signal and the triggering condition is then based upon that physiological characteristic value.
  • the triggering condition can be situations where the physiological characteristic value exceeds a predetermined threshold value.
  • a physiological characteristic monitor including an input device capable of receiving a signal from a sensor, a processor for analyzing the received signal and determining physiological characteristic value data of the user from the received signal, a memory for storing the physiological characteristic value data of the user and a display.
  • the signal is based on a physiological characteristic value of a user.
  • the display provides a retrospective display of the physiological characteristic value data.
  • the stored physiological characteristic value data includes a minimum and maximum blood glucose value and the retrospective display shows the minimum and maximum blood glucose value with a respective time and date.
  • the stored physiological characteristic value data can include a first number of excursions above an upper blood glucose value and a second number of excursions below a lower blood glucose value and the retrospective display shows the first and second number.
  • the stored physiological characteristic value data can include a distribution of blood glucose values and the retrospective display shows a first portion of the blood glucose values above an upper blood glucose value, a second portion of the blood glucose values below a lower blood glucose value and a third portion of the blood glucose values between the upper value and the lower value.
  • the portions can be shown as percentages, times or numbers of readings.
  • the display can include a total time for the physiological characteristic value data as well as the total number of readings for the physiological characteristic value data.
  • the first portion and the second portion can be shown as integrated values. The integrated values can be based on the sums of magnitude differences from the upper blood glucose value and the lower blood glucose value for the first and second portion, respectively. In such embodiments, the integrated values can be divided by a respective duration of sensor use.
  • embodiments of the invention include a monitor that performs a status check routine based on sensor activity, sensor calibration and telemetry.
  • Other embodiments of the invention include a measurement entry time and value display for a monitor as well as a real-time and historical measurement display function.
  • FIG. 1A is a block diagram of a characteristic monitor embodiment of the present invention
  • FIG. 1B is a block diagram of a telemetered characteristic monitor embodiment of the present invention.
  • FIG. 2A is a flowchart of a status check algorithm for a characteristic monitor embodiment of the present invention
  • FIG. 2B is a flowchart of screens for entering a reference value to calibrate a characteristic monitor embodiment of the present invention
  • FIG. 3A is a flowchart of a method for anticipating a glucose crash
  • FIG. 3B is a flowchart of a method for detecting an inadequate nocturnal basal rate
  • FIG. 3C is a flowchart of a method for anticipating a hyperglycemic incident
  • FIG. 3D is a flowchart of a method for maximizing athletic performance
  • FIG. 4A illustrates a multiple alarm function of the invention
  • FIGS. 4B and 4C illustrate respectively hypoglycemia and hyperglycemia alarm screens
  • FIGS. 4D and 4E illustrate respectively flowcharts of screens for setting hypoglycemia and hyperglycemia alarms
  • FIG. 4F illustrates a flowchart of screens for setting a hyperglycemia alarm snooze
  • FIG. 4G illustrates a flowchart of screens for reviewing a history of glycemia alarms in accordance with an embodiment of the invention
  • FIG. 5 illustrates a reminder function of an embodiment of the invention
  • FIG. 6A illustrates minimum and maximum data presentation
  • FIG. 6B illustrates excursion data presentation
  • FIG. 6C illustrates characteristic value distribution data presentation
  • FIG. 6D illustrates integrated characteristic value data presentation
  • FIG. 7 illustrates screens for viewing real-time and historical measurements of a physiological characteristic value in an embodiment of the invention.
  • Embodiments of the present invention encompass methods and systems for the convenient operation of monitoring physiological characteristics (“characteristic monitoring systems”).
  • the description provided here encompasses the architecture of the apparatus as well as its control and convenience features.
  • the control and convenience features of the present invention can be implemented in a wide range of detailed characteristic monitoring system designs.
  • embodiments of the present invention are primarily described in the context of glucose monitors used in the treatment of diabetes, the embodiments of the invention are applicable to a wide variety of patient treatment programs where a physiological characteristic is periodically monitored to use in estimating the responsive treatment.
  • embodiments of the invention can be used to determine the status and/or levels of a variety of characteristics including those associated with agents such as hormones, cholesterol, medication concentrations, pH, oxygen saturation, viral loads (e.g., HIV), or the like.
  • a sensor for the characteristic monitor can be implanted in and/or through subcutaneous, dermal, sub-dermal, inter-peritoneal or peritoneal tissue. Such sensors typically communicate a signal from the sensor set to the characteristic monitor.
  • General embodiments of the invention include a physiological characteristic monitor coupled to a sensor set.
  • the sensor set and monitor are for determining glucose levels in the blood and/or body fluids of the user without the use of, or necessity of, a wire or cable connection between the transmitter and the monitor.
  • Embodiments of the characteristic monitor system of the invention are primarily adapted for use in subcutaneous human tissue.
  • embodiments of the invention can be placed in a variety of other types of physiological milieus, such as muscle, lymph, organ tissue, veins, arteries or the like, as well as being used in related environments such as animal tissue.
  • Embodiments of the invention can provide sensor readings on an intermittent, near-continuous or continuous basis.
  • Embodiments of the invention include sensing and advanced predictive functions of the monitor which are designed to anticipate unsafe conditions for a user before they occur.
  • predictive functions can be employed so that a user can obtain feedback to obtain a desired physical objective, such as maximizing athletic performance.
  • Other functions of the monitor include multiple programmable alarms and reminders and diagnostic functions.
  • Advanced alarm functions also include an alarm repeat delay function and a snooze function that can be set by a user.
  • Embodiments of the invention can include advanced display tools to facilitate easy and quick interpretation of information related to the user's condition, including a display function for an alarm history as well as a history of measurements.
  • FIG. 1 A is a block diagram of a characteristic monitoring system 100 in accordance with an embodiment of the present invention.
  • the characteristic monitoring system 100 generally includes a sensor set 102 that employs a sensor that produces a signal that corresponds to a measured characteristic of the user, such as a blood glucose level.
  • the sensor set 102 communicates these signals to a characteristic monitor 104 that is designed to interpret these signals to produce a characteristic reading or value for the user, i.e. a measurement of the characteristic.
  • the sensor signals enter the monitor 104 through a sensor input 106 and through the sensor input 106 the signals are conveyed to a processor 108 .
  • the processor 108 determines and manipulates the sensor readings within the monitor 104 .
  • the characteristic monitor 104 provides additional functions that will aid in the treatment regime to which the characteristic reading applies.
  • the monitor may track meals, exercise and other activities which affect the treatment of diabetes. These additional functions can be combined with or independent from the characteristic readings determined by the monitor 104 .
  • monitor 104 Other components of the monitor 104 support the processor 108 in performing functions.
  • a memory 110 is used to store data and instructions used by the processor 108 .
  • a data entry device 112 such as a keypad is used to receive direct input from the user and a display 114 such as a liquid crystal display (LCD), or the like, is used to relate information to the user.
  • the monitor 104 includes a data port 116 , such as a digital input/output (I/O) port.
  • I/O digital input/output
  • the data port 116 can be used for the monitor 104 to communicate with a computer 118 .
  • the monitor 104 may interface with the computer 118 through a communication station 120 that can serve as a docking station for the monitor 104 , for example.
  • the data port 116 within the monitor 104 can be directly connected to the computer 118 .
  • data may be downloaded from the monitor 104 , such as stored characteristic readings, settings, programs and other information related to the monitor's function.
  • advanced analysis can be performed on the computer 118 , freeing memory 110 within the monitor 104 .
  • Data such as characteristic readings, settings and programs can also be downloaded to the monitor 104 . In this way, the monitor 104 can be conveniently reprogrammed without requiring tedious manual entry by the user.
  • FIG. 1B is a block diagram of a telemetered characteristic monitoring system embodiment of the invention.
  • the sensor input 106 of the monitor 104 is a wireless receiver, such as a radio frequency (RF) receiver.
  • the sensor set 102 provides a signal via wired link to a telemetered monitor transmitter 202 , where the signal is interpreted and converted to an RF signal.
  • the wireless receiver sensor input 106 of the monitor 104 converts the signal to data understandable to the monitor processor.
  • the telemetered characteristic monitoring system can perform any or all the functions of the characteristic monitoring system of FIG. 1A .
  • a characteristic monitoring system 100 includes a sensor set 102 and characteristic monitor device 104 .
  • the sensor set 102 generally utilizes an electrode-type sensor.
  • the system can use other types of sensors, such as electrically based sensors, chemically based sensors, optically based sensors, or the like.
  • the sensors can be of a type that is used on the external surface of the skin or placed below the skin layer of the user. Preferred embodiments of a surface mounted sensor utilize interstitial fluid harvested from underneath the skin.
  • the sensor set 102 is connected to the monitor device 104 and provides a signal based upon the monitored characteristic (e.g., blood glucose).
  • the monitored characteristic e.g., blood glucose
  • the characteristic monitor device 104 utilizes the received signal to determine the characteristic reading or value (e.g., a blood glucose level).
  • the sensor may be placed in other parts of the body, such as, but not limited to, subcutaneous, dermal, sub-dermal, inter-peritoneal or peritoneal tissue
  • the telemetered characteristic monitor transmitter 202 generally includes the capability to transmit data.
  • the telemetered characteristic monitor transmitter 202 can include a receiver, or the like, to facilitate two-way communication between the sensor set 102 and the characteristic monitor 104 .
  • the characteristic monitor 104 can be replaced with a data receiver, storage and/or transmitting device for later processing of the transmitted data or programming of the telemetered characteristic monitor transmitter 202 .
  • a relay or repeater (not shown) can be used with a telemetered characteristic monitor transmitter 202 and a characteristic monitor 104 to increase the distance that the telemetered characteristic monitor transmitter 202 can be used with the characteristic monitor 104 .
  • the relay can be used to provide information to parents of children using the telemetered characteristic monitor transmitter 202 and the sensor set 102 from a distance. The information can be used when children are in another room during sleep or doing activities in a location remote from the parents.
  • the relay can include the capability to sound an alarm.
  • the relay can be capable of providing telemetered characteristic monitor transmitter 202 data from the sensor set 102 , as well as other data, to a remotely located individual via a modem connected to the relay for display on a monitor, pager or the like.
  • the data can also be downloaded through the communication station 120 to a remotely located computer 118 such as a PC, laptop, or the like, over communication lines, by modem or wireless connection.
  • some embodiments of the invention can omit the communication station 120 and use a direct modem or wireless connection to the computer 118 .
  • the telemetered characteristic monitor transmitter 202 transmits to an RF programmer, which acts as a relay, or shuttle, for data transmission between the sensor set 102 and a PC, laptop, communication station 118 , a data processor, or the like.
  • the telemetered characteristic monitor transmitter 202 can transmit an alarm to a remotely located device, such as a communication station 118 , modem or the like to summon help.
  • further embodiments can include the capability for simultaneous monitoring of multiple sensors and/or include a sensor for multiple measurements.
  • a purpose of the characteristic monitoring system 100 is to provide for better treatment and control in an outpatient or a home use environment.
  • the monitoring systems 100 , 200 can provide indications of glucose levels, a hypoglycemia/hyperglycemia alarm and outpatient diagnostics.
  • Embodiments of the invention are also useful as an evaluation tool under a physician's supervision.
  • the characteristic monitor device 104 receives characteristic information, such as glucose data or the like, from the sensor set 102 and displays and/or logs the received glucose readings. Logged data can be downloaded from the characteristic monitor 104 to a PC, laptop, or the like, for detailed data analysis.
  • the characteristic monitoring system 100 , 200 can be used in a hospital environment, or the like. Still further embodiments of the present invention can include one or more buttons to record data and events for later analysis, correlation, or the like. Further buttons can include a sensor on/off button to conserve power and to assist in initializing the sensor set 102 .
  • the characteristic monitoring system 200 can also be employed with other medical devices to combine other patient data through a common data network system.
  • the sensor set 102 can monitor the temperature of the sensor set 102 , which can then be used to improve the calibration of the sensor.
  • the enzyme reaction activity may have a known temperature coefficient. The relationship between temperature and enzyme activity can be used to adjust the sensor values to more accurately reflect the actual characteristic levels.
  • the oxygen saturation level can be determined by measuring signals from the various electrodes of the sensor set 102 . Once obtained, the oxygen saturation level can be used in calibration of the sensor set 102 due to changes in the oxygen saturation levels and its effects on the chemical reactions in the sensor set 102 . For example, as the oxygen level goes lower, the sensor sensitivity can be lowered.
  • temperature measurements can be used in conjunction with other readings to determine the required sensor calibration.
  • the sensor set 102 facilitates accurate placement of a flexible thin film electrochemical sensor of the type used for monitoring specific blood parameters representative of a user's condition.
  • the sensor monitors glucose levels in the body, and can be used in conjunction with automated or semi-automated medication infusion devices of the external or implantable type as described in U.S. Pat. Nos. 4,562,751; 4,678,408; 4,685,903 or 4,573,994 (which are incorporated herein by reference), to control delivery of insulin to a diabetic patient.
  • Embodiments of the flexible electrochemical sensor can be constructed in accordance with thin film mask techniques to include elongated thin film conductors embedded or encased between layers of a selected insulative material, such as polyimide film or sheet, and membranes.
  • the sensor electrodes at a tip end of the sensing portion are exposed through one of the insulative layers for direct contact with patient blood or other body fluids, when the sensing portion (or active portion) of the sensor is subcutaneously placed at an insertion site.
  • the sensing portion is joined to a connection portion that terminates in conductive contact pads, or the like, which are also exposed through one of the insulative layers.
  • other types of implantable sensors such as chemical based, optical based, or the like, can be used.
  • connection portion can be conveniently connected electrically to the monitor 104 or a telemetered characteristic monitor transmitter 202 by a connector block (or the like) as shown and described in U.S. Pat. No. 5,482,473, entitled “FLEX CIRCUIT CONNECTOR”, which is also herein incorporated by reference.
  • subcutaneous sensor sets 102 are configured or formed to work with either a wired or a wireless characteristic monitoring system 100 , 200 .
  • the physiological characteristic monitoring system 100 , 200 can perform a status check to confirm that the monitor 104 is operating properly and calibrated to take glucose measurements.
  • the processor 108 determines the status of the monitor for receiving the signal from the sensor set 102 .
  • the monitor status is based upon at least one of a plurality of conditions including the sensor activity condition, the sensor calibration condition and the telemetry condition.
  • the display 114 shows different observable indicators depending upon the status of the monitor 104 .
  • FIG. 2A is a flowchart 220 of an exemplary status check algorithm for a characteristic monitor embodiment of the present invention.
  • a user can press a key (e.g. the UP key) to initiate the status check.
  • the processor 108 first performs a sensor activity condition check 224 to determine if there is an expired or dead sensor. If the sensor is determined to be dead, the display 114 shows a sensor “REPLACE” prompt 226 with the current time, which indicates that the sensor has expired and replacement of the sensor set 102 is required immediately.
  • the processor 108 performs a telemetry condition check 228 to determine if the monitor 104 is synchronized with the telemetered monitor transmitter 202 coupled to the sensor set 102 . If the monitor 104 and the transmitter 202 are not synchronized, a “NO SYNC” indicator 230 is shown on the display 114 . If the devices are synchronized, a calibration condition check 232 is performed by the processor 108 to determine first whether a calibration of the sensor set 102 is pending (i.e., whether the monitor 104 is currently processing a previously entered blood glucose reference value, for example from a meter, to calibrate the sensor set 102 ).
  • the display 114 shows a “PENDING” indicator 234 . If a calibration is not pending, the processor 108 checks whether the sensor calibration is currently valid 236 . If the calibration is not valid, the display shows an “ENTER BG” indicator 242 with the current time, which indicates that a blood glucose reference value (e.g., from a blood glucose meter) is required by the monitor 104 to calibrate the sensor set 102 . If the calibration is valid, the processor 108 then checks that the sensor expiration time is after the next calibration due time 238 , and the display 114 shows a “BG DUE” indicator 240 with the time that the next calibration is due. If the sensor expiration time is before the next calibration due time, the display 114 shows the “REPLACE” prompt 226 with the time that the sensor will expire and replacement of the sensor set 102 will be required.
  • a blood glucose reference value e.g., from a blood glucose meter
  • FIG. 2B is an exemplary flowchart 250 of screens for entering a reference value to calibrate a characteristic monitoring system 100 , 200 in accordance with an embodiment of the present invention.
  • a calibration is pending or valid as a result of entry of a calibration reference value (e.g., a blood glucose value measured by a blood glucose meter)
  • the display 114 shows the calibration reference value and time of the most recent valid entry in the meter screen 252 .
  • the time of the most recent valid entry is unaffected by a change in a system time setting of the monitor 104 .
  • the time of the most recent valid entry may be shifted in accordance with a change in a system time setting of the monitor 104 .
  • pressing a button allows entry of a new calibration reference value in the entry screen 254 .
  • the display 114 shows a confirmation screen 256 , which requires confirmation of the value entered (e.g., by pressing the ACT/activate button) to release the display to the default time screen 258 .
  • Embodiments of the present invention include different types of continuous glucose monitors that identify trends in blood glucose dynamics to facilitate enhanced treatment of diabetes.
  • a first illustrative monitor can be used to anticipate a glucose “crash” (or other hypoglycemic incident) before the onset of debilitating symptoms.
  • Another illustrative monitor can be used to detect an inadequate nocturnal basal rate and alert the patient in order to avoid an impaired fasting glucose incident.
  • Another illustrative monitor can anticipate hyperglycemic (or hypoglycemic) incidents by detecting trends toward those levels and help the patient avoid such incidents.
  • Another illustrative monitor can assist a patient in maximizing athletic performance in endurance type activities (e.g., a marathon race) by detecting trends toward hypoglycemic levels.
  • the disclosed embodiments monitor the dynamics of a physiological characteristic such as blood glucose levels. These embodiments utilize this dynamic monitoring to provide functionality including the anticipation of glucose crash and alerting the patient, the detection of inadequate nocturnal basal rate, the anticipation of hyperglycemic (or hypoglycemic) incidents and maximizing athletic performance. All of these features can be implemented in software operating in the monitor's microprocessor and/or designed into an application specific integrated circuit (ASIC) or other specialized circuitry. Also, dynamic glucose monitoring functions use periodic measurements of a glucose level.
  • ASIC application specific integrated circuit
  • a monitor anticipates a glucose crash by monitoring trends in glucose levels. For example, the monitor can alert the patient when glucose levels are rapidly decreasing. By monitoring such trends or a rate information of measured glucose levels, the monitor can provide a much better warning system to alert the user with enough time to stabilize and reverse a dangerous physiological condition.
  • the monitor measures glucose more frequently than typical glucose monitoring devices. For example, one embodiment of the invention measures approximately every minute, whereas other monitors measure at a lower rate (e.g., but not limited to, once per 5 minutes). Frequent measurements are taken because of the short time intervals which are evaluated. Alternative embodiments may utilize more frequent measurements, such as, but not limited to, 10 seconds, 1 second, or the like.
  • the monitor periodically measures glucose, analyzes the present trend, determines whether a glucose crash incident is probable and appropriately alerts the patient.
  • the device measures the glucose level, applies a smoothing filter to the result, and records the filtered value.
  • the smoothing filter may take a weighted sum of past sensor values (so called finite impulse response—FIR—filter), a weighted sum of past sensor values and past filtered values (so called infinite impulse response—IIR—filters), may use simple clipping algorithms (e.g. limit the percent change in filtered output), or employ models to predict the output (e.g. Weiner and Kalman filter designs).
  • the monitor can calculate the slope of a line fit to the most recent values (most likely, but not limited to, using a Saritzky gulag filter) and determine if the slope is steeper than a selected threshold rate (e.g., but not limited to, 3% or declining at more than 30 mg/dL in ten minutes). If the slope equals or exceeds the threshold rate, a glucose crash incident is likely and the monitor alerts the patient accordingly.
  • a selected threshold rate e.g., but not limited to, 3% or declining at more than 30 mg/dL in ten minutes.
  • the qualifying range can be a closed range (e.g., but not limited to, between 100 and 150 mg/dL) and in other embodiments the qualifying range can be an open range (e.g., but not limited to, greater than 100 mg/dL).
  • the determination of a glucose crash can be unconcerned with rate magnitudes occurring when the current characteristic value is outside of the range (of course, other alarms, which merely monitor the current characteristic value, can be triggered when the reading is too high or too low).
  • the slope can be calculated and compared to the threshold rate with every new value.
  • multiple qualifying ranges and threshold rates can be applied to evaluate the glucose dynamics and determine triggering a glucose crash warning.
  • the monitor determines that a glucose crash is likely if three criteria are met.
  • the criteria are as follows.
  • the third, G, the glucose level can be considered for example, when this value begins dropping starting within a specified range, (e.g., but not limited to, 100-150 mg/dL).
  • these criteria can be parameterized to allow the user to customize the values.
  • the qualifying range, threshold rate and period can be general values, applied to all users, or determined from factors specific to the individual user.
  • the monitor can include a feature to adjust the qualifying glucose level range, the maximum rate of glucose change, or in some embodiments, the sustained time period length.
  • any or all of the dynamic glucose monitoring functions can enabled or disabled, selectively or together.
  • control program pseudo code provides an example of a programming routine performed by the processor of the monitor to implement an embodiment of the invention.
  • REPEAT every minute ⁇ Measure glucose level g i Filter g i and store the filtered value g′ i IF(g′ i is in range 100 - 150 mg/dL) THEN Fit a line to the most recent 10 filtered (or, alternatively, unfiltered) values IF (dG/dT for that line ⁇ ( ⁇ 3% per minute ) THEN Alert the patient and record in history ENDIF ENDIF ⁇ END REPEAT
  • FIG. 3A is a flowchart of a method for anticipating a glucose crash 300 .
  • a characteristic level is repeatedly measured to obtain a group of characteristic level values.
  • a smoothing filter can be applied to the group of characteristic level values to produce a filtered measurement value.
  • the filtered measurement value is recorded at block 306 .
  • it is determined if the recorded value falls within a qualifying range e.g., but not limited to, between 100 to 150 mg/dL). If not, the process returns to block 302 . If the recorded measurement is within the range, a slope of a line fit to a recent series of recorded filtered values is calculated at block 310 .
  • the calculated slope is compared to a threshold rate (e.g., but not limited to, ⁇ 3% per minute) at block 312 . If the calculated slope is not steeper than the threshold rate the process returns to block 302 . If the slope exceeds the threshold rate, an anticipated glucose crash is indicated at block 314 .
  • a threshold rate e.g., but not limited to, ⁇ 3% per minute
  • Alternative embodiments may utilize similar logic for when the glucose level is already outside of the range and continues to drop.
  • a raw data measurement e.g. a group of characteristic level values
  • the characteristic monitor can be used to detect an inadequate nocturnal basal rate.
  • This embodiment generally applies to diabetic patients using an insulin infusion device that continually administers insulin at a patient controlled basal rate.
  • the monitor detects an inadequate basal rate (i.e., but not limited to, “low basal rate” or a “high basal rate”), by monitoring trends in glucose levels.
  • the monitor alerts a patient in the early morning, when glucose levels are high and relatively steady, low and relatively stable or changing rapidly. This gives the patient time to adjust the basal rate of the infusion device upward or downward to and avoid an impaired fasting glucose incident.
  • the monitor operates to track the characteristic level rate. For example, every 5 minutes the monitor measures and records the glucose level. Once a day (e.g., but not limited to, 3 hours before to the anticipated wakeup time), the monitor calculates the average blood glucose and the rate of blood glucose change for the previous hour. The monitor can then determine a prediction of the “morning glucose” level at wake up based upon the calculated average blood glucose and the rate of blood glucose change. In one embodiment the “morning glucose” is predicted assuming that the rate of change remains constant, however in other embodiments nonlinear characteristic curves and functions can be applied in making the prediction.
  • a high threshold value e.g., but not limited to, 126 mg/dL
  • a low threshold value e.g., but not limited to, 60 mg/dL
  • an alarm is sounded. This will allow time for the infusion device basal rate to be adjusted appropriately.
  • different times before anticipated wakeup, different high threshold values, or different low threshold values may be used.
  • the triggering criteria can also be parameterized to allow the user to customize the values.
  • the user is allowed to set the values for the controlling parameters. For example, the user can set the qualifying low and high glucose levels as well as the anticipated waking time. For each of the settings a default value can be used in the absence of a user setting. For example, a default low glucose level of 60 mg/dL, a default high glucose level of 126 mg/dL and an anticipated waking time of 7:00 AM can be used. In addition, the entire function can be enabled and disabled.
  • FIG. 3B is a flowchart of a method for detecting an inadequate nocturnal basal rate 320 .
  • the method begins by measuring a characteristic level to obtain a measurement value. The value is recorded at block 324 . Measuring and recording is repeated periodically to obtain a series of values at block 326 .
  • the average of the series of values is calculated.
  • a slope of a line fit to the series of values is calculated. The calculated slope and average of the series of values are then used to determine a predictive curve at block 332 .
  • the curve is extrapolated to predict a glucose level at wakeup.
  • the extrapolation is performed some time before wakeup (e.g., but not limited to, 3 hours prior) to provide enough time to correct any impending negative condition.
  • the predicted glucose level is compared to an acceptable range at block 336 . If the predicted glucose value falls within the range, the process ends. If the predicted glucose value falls outside the range, a morning glucose incident is reported at block 338 .
  • a glucose monitor anticipates a hyperglycemic (or hypoglycemic) incident by monitoring trends in glucose levels.
  • the monitor alerts the patient when a “relatively steady increase” (or decrease) in glucose levels occurs.
  • the monitor periodically measures glucose, analyzes the present trend, determines whether a hyperglycemic (or hypoglycemic) incident is probable and appropriately alerts the patient.
  • the device measures glucose values at a specific time interval (e.g. once every minute), and then, e.g. at 5 minute intervals, applies a smoothing filter to this group of values and records the filtered value. If the most recent (filtered) value exceeds a threshold value (e.g., but not limited to, 180 mg/dL), the monitor calculates the slope of a line fit to a recent series of recorded values (for example, but not limited to, six values). If the slope is greater than a threshold rate (e.g., but not limited to, 3% per minute), a hyperglycemic incident is likely and the monitor alerts the patient. For hypoglycemic incidents, values and thresholds corresponding to low glucose levels would be used.
  • a threshold value e.g., but not limited to, 180 mg/dL
  • a threshold rate e.g., but not limited to, 3% per minute
  • the threshold value is applied in a similar manner to the “qualifying range” applied in determining a glucose crash previously discussed.
  • the threshold value effectively operates as an open range (e.g., but not limited to, greater than 180 mg/dL).
  • the threshold value can be a closed range. Therefore, determining a hyperglycemic incident can be unconcerned with values below the threshold value (as determining a hypoglycemic incident can be unconcerned with values above a threshold value).
  • a slope calculation can be avoided if the current reading is outside the range. However, in alternate embodiments, the slope can be calculated and compared to the threshold rate with every new reading.
  • multiple qualifying ranges and threshold rates can be applied to evaluate the glucose dynamics and determine triggering a hyperglycemic (or hypoglycemic) incident warning.
  • the criteria can be parameterized to allow the user to customize the controlling values for anticipating hyperglycemic (or hypoglycemic) incidents.
  • some embodiments can allow the user to set the glucose threshold level and/or the threshold rate.
  • Embodiments of the invention can also use default parameters if no user settings are provided (e.g., but not limited to, a threshold level of 180 mg/dL and a maximal rate of 3% per minute). Embodiments of the invention can also enable and disable this function.
  • FIG. 3C is a flowchart of a method for anticipating a hyperglycemic incident 350 .
  • the method begins at block 352 by repeatedly measuring a characteristic level to obtain a group of values.
  • a smoothing filter is applied to the group of values to obtain a filtered measurement value.
  • the filtered value is recorded at block 356 .
  • the recorded value is compared to a threshold value at block 358 . If the recorded value does not exceed the threshold value (e.g., but not limited to, 180 mg/dL), the process returns to block 352 . If the recorded value does exceed the threshold value, a slope of a line fit to a recent series of values is calculated at block 354 .
  • the threshold value e.g., but not limited to, 180 mg/dL
  • Dynamic monitoring can also be used to provide feedback based upon the engaged activity of the user.
  • the monitor can be used to maximize performance during an endurance type activity (e.g., but not limited to, a marathon race).
  • the endurance athlete strives to burn glucose rather than fat and accordingly needs to anticipate low glucose levels and ingest carbohydrates early enough to avoid low glucose levels.
  • the monitor anticipates low glucose levels and alerts the athlete to ingest carbohydrates. It is important to note that this embodiment is not strictly anticipating hypoglycemic incidents. Instead it is anticipating low glucose levels where it would otherwise be too late for the athlete to compensate by ingesting carbohydrates and still perform effectively and/or at full capacity.
  • the device measures a glucose level, applies a smoothing filter and records the filtered value at 5-minute intervals. If the most recent recorded (i.e., filtered) value is in a qualifying range (e.g., but not limited to, 60-140 mg/dL), the processor calculates the slope of a line fit to the most recent six filtered values and determines if the slope is steeper than ⁇ 1% (i.e., but not limited to, 30 mg/dL in 30 minutes). If the rate of decline exceeds this threshold, a low glucose level is likely and the monitor alerts the athlete accordingly. Thus, for example, but not limited to, to trigger an alarm, the glucose level rate, dG/dT, is negative with a magnitude greater than 1% per minute for 30 minutes beginning in range 60-140 mg/dL.
  • a qualifying range e.g., but not limited to, 60-140 mg/dL
  • the qualifying range can be a closed range (e.g., but not limited to, between 60 and 140 mg/dL) or an open range (e.g., but not limited to, less than 140 mg/dL).
  • a closed range e.g., between 60 and 140 mg/dL
  • an open range e.g., but not limited to, less than 140 mg/dL.
  • the monitor will allow a user to set the qualifying glucose range and/or enable and disable the function.
  • a default qualifying range e.g., but not limited to, 60-140 mg/dL can be used.
  • FIG. 3D is a flowchart of a method for maximizing athletic performance 370 .
  • the process begins at block 372 , where a characteristic level is repeatedly measured to obtain a group of characteristic level values. Following this at block 374 , a smoothing filter can be applied to the group of characteristic level values to produce a filtered measurement value.
  • the filtered measurement value is recorded at block 376 .
  • a qualifying range e.g., but not limited to, between 60 to 140 mg/dL
  • the calculated slope is compared to a threshold rate (e.g., but not limited to, ⁇ 1% per minute) at block 382 . If the calculated slope is not steeper than the threshold rate the process returns to block 372 . If the slope exceeds the threshold rate, an anticipated low glucose level is indicated at block 384 . As noted previously, estimates of dG/dt may be calculated by slope as well as other methods known in the art.
  • a threshold rate e.g., but not limited to, ⁇ 1% per minute
  • Embodiments of the invention can utilize various advanced alarm functions. For example, in some embodiments multiple alarms can be independently set by the user. In further embodiments, user input can direct review of the alarm history and also alter the alarm display to suit the user's preference. Alarm settings for embodiments of the invention can also include an alarm snooze or “blackout” period as well as an alarm repeat delay.
  • Embodiments of the invention can employ multiple alarms that can be independently set by the user.
  • a continuous glucose monitoring system can have multiple alarms for different glucose values.
  • the system can allow a user to set threshold glucose values that define a “narrow” glucose range (as compared to the ordinary alarm limits). If the user's glucose level passes outside the “narrow” range, an alarm can sound. This alarm alerts the user to monitor his glucose levels more closely.
  • the system can sound a second alarm (preferably having a sound distinguishable from the first “narrow” range alarm) in the event the user's glucose level reaches a more dangerous condition requiring immediate action.
  • Alarm indications may be audible, tactile, vibratory, visual, combinations of alarm indications, or the like.
  • visual alarm indications but not limited to, green lights can be displayed while the user's glucose level remains within the defined “narrow” range; yellow for the first alarm level; and red for the second alarm level.
  • the visual alarm indications may flash and/or also be combined with other alarm indications.
  • the alarms can be set in ranges, or separate high and low glucose level alarms can be set. Distinctive sounds can be used for each alarm. For example, each successive high glucose level alarm can have, but is not limited to having, a higher pitch. Successive low glucose level alarms can each have, but are not limited to having, lowering pitches. Alternately, intermittent or wavering volumes that also increase in pitch according to the severity of the condition can be used. In still other embodiments, the user can select or program alarm tones and other sounds and assign them to the various alarms. Also, in some embodiments, these distinguishable alarms can also be set at different volume levels. In addition, as discussed above, the alarms are not limited to audible signals; some embodiments of the invention can also utilize visual alarms, such as flashing lights or displays, or tactile alarms, such as vibrating indicators.
  • threshold values and associated alarms can be set according to a schedule. For example, but not limited to, particular alarms can be set to be active only during selected portions of the day.
  • FIG. 4A illustrates a multiple alarm function of the invention.
  • a plot of the monitored characteristic value 400 e.g., blood glucose
  • a typical wide alarm range 402 is defined by an upper threshold value 404 and a lower threshold value 406 . If the monitored characteristic value 400 should exceed the defined range and cross either threshold, an alarm is initiated to indicate to the user to check his blood glucose.
  • a distinctive alarm can be associated with the alarm range 402 . Thus, the same alarm is produced whether the range 402 is exceeded by passing the upper threshold value 404 or the lower threshold value 406 .
  • distinctive alarms can be assigned to each threshold value 404 , 406 .
  • other alarm ranges can also be set.
  • a second narrower range 408 can be set with a lower upper threshold value 410 than that of the wider range 402 ; and a higher lower threshold value 412 than that of the wider range 402 .
  • an alarm is initiated if the narrower range is exceeded by the monitored characteristic value 400 .
  • alarms can be the same or different for each threshold value 410 , 412 .
  • the ability to set different ranges and associated alarms allows the monitor to immediately convey some information about the condition of the user even before checking the actual readings.
  • using the narrower range 408 and associated alarms allows the user to know of a negative trend that does not require the same urgency as an alarm triggered by the wider range 402 .
  • the user is able to set multiple alarms, each indicating a different level of urgency and/or different conditions.
  • threshold values for alarms can also be set independent from ranges.
  • alarms or indicators can be set according to the direction in which a threshold value is crossed by the monitored characteristic value 400 .
  • a threshold value For example, as the monitored characteristic value 400 crosses a lower threshold value 412 from the narrow range (e.g., but not limited to, at point 414 ), one type of alarm can be provided. However, when the monitored characteristic value 400 crosses a lower threshold value 412 from the wider range 402 (e.g., but not limited to, at point 416 ), another type of alarm can be provided.
  • the difference in the alarms is appropriate because only the former case indicates a worsening of the user's condition. In the latter case, the transition actually indicates an improvement in the user's condition.
  • alarms will only be given when crossing a threshold indicates a worsening of the user's condition.
  • an indicator will also be given when a threshold has been crossed in an improving direction.
  • either the same indicator (sound, light, display or other) or different indicators can be used.
  • reminders can be set to indicate to a user various conditions (not necessarily negative) that will aid in convenient therapy management.
  • the multiple alarm function of the invention can be readily incorporated with any of the individual alarm functions and settings such as discussed hereafter.
  • a physiological characteristic monitor can incorporate various individual alarm functions and settings to enhance convenient operation by a user.
  • the monitor includes a sensor input capable of receiving a signal from a sensor, the signal being based on a sensed physiological characteristic value of a user, and a processor for operating an alarm based on user input from an input device.
  • the alarm indicates an alarm condition where the sensed physiological characteristic value exceeds a set range.
  • the physiological characteristic value is a measurement related to a blood glucose level in the user and the alarm indicates a glycemic condition.
  • Operating the alarm comprises setting parameters of the alarm based on the user input from the input device.
  • the blood glucose level or value that will activate a hypoglycemia or hyperglycemia alarm may be set by the user utilizing the input device.
  • the hypoglycemia alarm may be set to trigger if the user's blood glucose level is less than or equal to 60, 65, or 70 mg/dl (or any other desired level)
  • the hyperglycemia alarm may be set to trigger if the user's blood glucose level is greater than or equal to 150, 160, or 175 mg/dl (or any other desired level).
  • FIGS. 4B and 4C illustrate the hypoglycemia and hyperglycemia alarm screens, respectively.
  • the display shows the measurement of the concentration of blood glucose indicating the glycemic condition, preferably until the alarm is acknowledged by the user.
  • the display shows a time of the alarm.
  • the alarm indicates the glycemic condition only if the monitor is calibrated, although in alternative embodiments, the alarm may indicate the glycemic condition regardless if the monitor is calibrated.
  • the display shows a LOW indicator when the measurement of the concentration of blood glucose is below a specified level for a hypoglycemia alarm, such as 60 mg/dl.
  • the display shows a HIGH indicator when the measurement of the concentration of blood glucose is above a specified level for a hyperglycemia alarm, such as 150 mg/dl.
  • alarm indications may be other visual indicators (e.g., lights, flashing displays, or the like), audible, tactile, and/or vibratory.
  • a hypoglycemia alarm can be indicated by at least two audible descending tones
  • a hyperglycemia alarm can be indicated by at least two audible ascending tones.
  • an alarm repeat delay period is employed. Subsequent alarms are prevented for the alarm repeat delay period after the measurement of the concentration of blood glucose first indicates a glycemic condition.
  • the alarm repeat delay period can be less than 20 minutes (e.g. approximately 17.5 minutes) for the glycemic condition comprising a hypoglycemic condition.
  • the alarm repeat delay period is less than 1 hour (e.g. approximately 52.5 minutes) for the glycemic condition comprising a hyperglycemic condition.
  • the alarm repeat delay period may be other time periods, such as 10 minutes, 15 minutes, 30 minutes, 11 ⁇ 2 hours, 2 hours, or the like.
  • the level of the measurement of the concentration of blood glucose from the sensor that will trigger a low limit (or hypoglycemia) alarm or a high limit (or hyperglycemia) alarm can be set based upon input from the user. Particularly, these two alarm levels can be separately set.
  • FIGS. 4D and 4E show exemplary hypoglycemia and hyperglycemia alarm setting algorithms, respectively.
  • FIG. 4D shows an exemplary hypoglycemia alarm setting flowchart 420 . To begin setting the hypoglycemia alarm, from the hypoglycemia alarm setting screen 422 , the ACT/activate button is pressed, and the hypoglycemia alarm activation screen 424 is entered.
  • the user can select setting the hypoglycemia alarm on, off or entering the alarm repeat setting function menu. If the user sets the hypoglycemia alarm off and presses the ACT/activate button, an alarm off confirmation screen 426 is presented. If the hypoglycemia alarm is set on and the ACT/activate button is pressed, the low limit entry screen 428 is presented. The low limit entry screen 428 allows the user to scroll through low limit alarm level settings using up and down arrow buttons to specify that the hypoglycemia alarm will trigger if the user's blood glucose level is less than or equal to 60, 65, or 70 mg/dl, or any other desired level. After setting the low limit alarm level, pressing the ACT/activate button again presents a hypoglycemia low limit alarm level confirmation screen 430 for confirming the specified hypoglycemic blood glucose level.
  • the alarm repeat display screen 432 is entered, which allows the user to set a period for delaying a repeated check of the hypoglycemia alarm condition.
  • the current alarm repeat delay period is shown in the alarm repeat display screen 432 .
  • Pressing the ACT/activate button allows the user to enter the repeat time select screen 434 .
  • the alarm repeat display screen 432 may be omitted, and the repeat time select screen 434 is entered once the alarm repeat setting function is selected. In the repeat time select screen 434 , the alarm repeat delay period blinks while being set by the user utilizing the input device.
  • the user can scroll through a list of delay increments and select the desired alarm repeat delay period from the list of delay increments.
  • the alarm repeat delay period has a default value of 20 minutes for the hypoglycemia (low limit) alarm level.
  • the scrolled list of delay increments can wrap around, beginning again when one end of the list is reached.
  • the alarm repeat delay period can be selected from a group of values differing in 10 minute increments.
  • the alarm repeat delay period can be selected from 20, 30, 40, 50 and 60 minutes for the low limit alarm level.
  • the alarm repeat delay period may be selected from a group of values differing in other time increments, such as 5, 15, or 20 minutes, or further, may be specified using up and down arrow buttons and then pressing the ACT/activate button. After selecting the alarm repeat delay period, pressing the ACT/activate button displays the alarm repeat delay confirmation screen 436 for confirming the period selection.
  • FIG. 4E shows an exemplary hyperglycemia alarm setting flowchart 440 .
  • the hyperglycemia alarm setting screen 442 if the ACT/activate button is pressed, the hyperglycemia alarm activation screen 444 is entered. From this screen 444 , the user can select setting the hyperglycemia alarm on, off or entering the alarm repeat setting function menu. If the user sets the hyperglycemia alarm off and presses the ACT/activate button, an alarm off confirmation screen 446 is presented. If the hyperglycemia alarm is set on and the ACT/activate button is pressed, the high limit entry screen 448 is presented.
  • the high limit entry screen 448 allows the user to scroll through high limit alarm level settings using up and down arrow buttons to specify that the hyperglycemia alarm will trigger if the user's blood glucose level is greater than or equal to 150, 160, 170, 175, or 180 mg/dl, or any other desired level.
  • pressing the ACT/activate button again presents a hyperglycemia high limit alarm level confirmation screen 450 for confirming the specified hyperglycemic blood glucose level.
  • the alarm repeat delay period for the hyperglycemia alarm is set in the same manner as that for the hypoglycemia alarm described above with respect to FIG. 4D ; however, the alarm repeat delay period is typically set separately for a low limit alarm level and a high limit alarm level because the desired delays are different in each case. In general, the hyperglycemia alarm repeat delay period may be longer than that of the hypoglycemia alarm. From the hyperglycemia alarm activation screen 444 , if the alarm repeat setting function is selected, the alarm repeat display screen 452 is entered, which allows the user to set a period for delaying a repeated check of the hyperglycemia alarm condition. The current alarm repeat delay period is shown in the alarm repeat display screen 452 .
  • Pressing the ACT/activate button allows the user to enter the repeat time select screen 454 .
  • the alarm repeat display screen 452 may be omitted, and the repeat time select screen 454 is entered once the alarm repeat setting function is selected.
  • the hyperglycemia alarm repeat delay period is selected in a manner similar to the hypoglycemia alarm repeat delay period described above with respect to FIG. 4D , and then pressing the ACT/activate button displays the alarm repeat delay confirmation screen 456 for confirming the period selection.
  • the alarm repeat delay period can have a default value of 1 hour for the hyperglycemia (high limit) alarm level.
  • the alarm repeat delay period can be selected from a group of values differing in 30 minute increments.
  • the alarm repeat delay period can be selected from 1, 11 ⁇ 2, 2, 21 ⁇ 2 and 3 hours for the hyperglycemia alarm level.
  • the alarm repeat delay period may be selected from a group of values differing in other time increments, such as 15 or 20 minutes or 1 hour, or further, may be specified using up and down arrow buttons and then pressing the ACT/activate button.
  • the multiple alarm function of the invention can be incorporated with various specific alarm features.
  • the alarm repeat delay function can be set differently for hypoglycemic alarms and hyperglycemic alarms of different severities. If a lower threshold hyperglycemic alarm is triggered, a relatively long repeat delay may be invoked. However, if a higher threshold hyperglycemic alarm is triggered, a shorter repeat delay may be used so that the user is warned more frequently because of the severity of his condition.
  • FIG. 4F illustrates a hyperglycemia alarm snooze setting flowchart 460 .
  • the hyperglycemia alarm snooze function sets an alarm snooze period for temporarily disabling the alarm.
  • the snooze function is set by the user utilizing the input device.
  • the alarm snooze period is only available for a hyperglycemia alarm, although in other embodiments, the alarm snooze period may also be available for a hypoglycemia alarm.
  • the snooze function is available only when the snooze period is running and the monitor is calibrated, although in alternative embodiments, the snooze function may be available regardless if the monitor is calibrated.
  • the alarm snooze period is preferably deactivated upon any adjustment of the hyperglycemia alarm setting described above with respect to FIG. 4E .
  • the snooze setting flowchart 460 begins at the snooze display screen 462 , which can be entered by scrolling past the default time screen 464 and the BG due screen 466 . From the snooze display screen 462 , pressing the ACT/activate button will produce the snooze time select screen 468 . In this screen 468 , a user can select the desired period for the snooze function to operate, and the alarm snooze period blinks while being set by the user utilizing the input device.
  • the alarm snooze period can be set by the user scrolling through a list of snooze period increments and selecting the desired alarm snooze period from the list of snooze period increments.
  • the list of snooze period increments can include 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours, and for convenience, the list of snooze period increments wraps around as it is scrolled by the user.
  • the snooze period may be selected from a list of other time increments, such as 15 or 30 minutes, or further, may be specified using up and down arrow buttons and then pressing the ACT/activate button.
  • the display shows time remaining of the alarm snooze period and an indicator (e.g. an “S”) showing that the snooze function is active.
  • both the alarm repeat delay function and the alarm snooze function prevent alarms for specified periods, they are not the same.
  • One difference between the two functions can generally be identified by how each function is initiated.
  • the alarm repeat delay is initiated (assuming the function is activated and set by the user) in response to a first alarm.
  • the alarm snooze function is activated by the user directly, either by directing the monitor to snooze immediately or scheduling a snooze at a specified time. For example, a user may schedule a snooze during sleeping hours that occur at some known time.
  • the multiple alarm function of the invention can also be incorporated with the alarm snooze function.
  • the snooze function can be set differently for hypoglycemic alarms and hyperglycemic alarms of different severities.
  • the snooze function can function normally when a lower threshold hyperglycemic alarm is set (i.e. ignore the alarm). However, when a higher threshold hyperglycemic alarm is set, the snooze function may be overridden due to the severity of the user's condition.
  • FIG. 4G illustrates glycemia alarm history review in accordance with an embodiment of the invention.
  • Operating the alarm history review can allow a user to review a historical list of the alarms indicating a glycemic condition occurrence.
  • the alarm history review flowchart 470 shows the alarm history is entered by pressing the ACT/activate button from the alarms menu screen 472 . If no alarm history exists, a screen 474 indicating “NONE” will be displayed. However, if at least one alarm event has occurred, the entries will be displayed in a historical list 476 .
  • the display shows a single glycemic alarm in the historical list at a time.
  • the display shows a physiological characteristic value (e.g.
  • the historical list typically includes a limited number of stored entries.
  • the historical list can comprise the 20 most recent alarms indicating a glycemic condition occurrence.
  • the historical list may include more or less alarms, such as the 10, 15, 30, or 50 most recent alarms.
  • the display can show the blood glucose measurements only within a specified range.
  • the specified range can be the operational range of the sensor, such as from 40 to 400 mg/dl, although the range may span other values, such as from 20 to 600 mg/dl.
  • the display shows a HI indicator.
  • the display shows a LO indicator for the measurements below the specified range.
  • the reminders can be alarm signals (including, but not limited to, auditory, visual, tactile, etc.) that are initiated after a timer has run to prompt the user to take action or merely inform the user of a particular status.
  • the reminder is started (i.e. the timer is initiated), when an event occurs and/or certain conditions are met.
  • the alarm signals can be the same or different based upon the triggering events or conditions.
  • reminders can be used to further assist the user in managing insulin delivery for optimum results. For example, but not limited to, reminders can be set for event markers, blood glucose values, reference values, high or low sensor measurements.
  • Characteristic monitors and infusion devices can use event markers that place tags in the data for events the user experiences (e.g., but not limited to, meals, exercise, and high or low blood glucose). For example, but not limited to, when an infusion device identifies a high or low blood glucose event marker, it can start a timer that reminds the user to check blood glucose levels. This is intended to make therapy safer by encouraging more frequent checks during times that the patient may be at risk from hypoglycemia or hyperglycemia. In addition, this feature can also be applied to characteristic monitors. For example, but not limited to, a characteristic monitor that is used to show low or high blood glucose tags can have a timer set to remind a user to check their blood glucose levels at a later time.
  • a reminder timer can be set that is triggered if a blood glucose value is entered.
  • the reminder can be if the user enters a low or high blood glucose value into the monitor as a reference or calibration value.
  • a reminder timer can also be triggered by a user providing a reference value to the monitor.
  • the user can be reminded to supply a new reference value after a minimum time period has elapsed. In this way calibration of the monitor is assured.
  • a blood glucose reminder can also be triggered by high or low measurement from the sensor.
  • the monitor will request a blood glucose reference value during an excursion away from the normal range of values.
  • the trigger for this reminder can be tempered by setting a minimum time between reminders to avoid pestering the user.
  • This reminder can be used to provide more robust data for curve fitting as correlation improves with variability in the data pairs.
  • the reminder promotes more frequent data collection during more critical periods (e.g., but not limited to, when blood glucose is too high or too low) and therefore the interpolated curve for this period is more reliably representative of the true curve.
  • reminders also serve to prevent redundant and excessive alarms for the user. For example, if the timer is removed from the previously described high or low measurement reminder, the result would be a simple hypoglycemia or hyperglycemia alarm. Using a reminder, however, the message is not that the user's blood glucose is out of range. Rather, the reminder's message is to check the user's blood glucose with a meter, or the like. If a user's blood glucose is very near an alarm triggering threshold, an alarm might be triggered repeatedly as the value passes back and forth across the threshold. A reminder will set a timer, preventing duplicative warnings for a short period of time, but reminding the user to check blood glucose again when that period has expired.
  • the alarm is triggered again, regardless of the presence of a time, if the glucose level continues to change in the direction of the trend.
  • FIG. 5 illustrates a reminder function of the invention triggered by high or low characteristic values.
  • a plot of a monitored characteristic value 500 (such as, but not limited to, blood glucose) is shown.
  • One or more ranges 502 , 504 define safe characteristic values (e.g., but not limited to, a first range 502 being a warning range and a second range 504 being a critical range), such as can be employed using multiple alarms as previously described.
  • a range is exceeded (e.g., but not limited to, at time 506 )
  • an alarm can be triggered but also a timer is started such that a reminder is also initiated after its expiration (e.g., but not limited to, at time 508 ). Over the timer period further occurrences of exceeding the threshold (e.g., but not limited to, at point 510 ) will not result in a duplicative alarm.
  • the situation can be somewhat different when the intervening triggering event is not identical to the first triggering event. For example, if a first range 502 is exceeded (e.g., but not limited to, at time 512 ) and a timer is started, but before a reminder can be issued (e.g., but not limited to, at time 514 ) a second range 504 is exceeded (e.g., but not limited to, at time 516 ), then the second alarm will be issued and the timer will be restarted.
  • a first range 502 e.g., but not limited to, at time 512
  • a timer is started, but before a reminder can be issued (e.g., but not limited to, at time 514 )
  • a second range 504 is exceeded (e.g., but not limited to, at time 516 )
  • Another aspect of the invention is to provide meaningful retrospective information to the patient using the sensor.
  • a retrospective display of one or more physiological values can provide significantly useful data.
  • the retrospective displays can be designed in a variety of ways to provide various useful information. For example, but not limited to, as the sleeping user receives no benefit from a real-time display, a retrospective view of data is important. While a simple listing of previous values has value, it can be time consuming to review, provides information that is difficult to visualize and comprehend and requires significant memory space within the device. Providing useful information that is easy to understand and that can be stored within a small memory space is very important.
  • the ability to review data from the previous sleep period is particularly helpful to a user with nocturnal hypoglycemia or “dawn effect”, as there is typically no witness to the real-time display. These measures can be even more important in cases where the alarm system can exhibit many false positives and/or false negatives, which might otherwise frustrate the user and lead to non-use of the monitor.
  • the following advanced data presentation tools can be used to conveniently and efficiently store and display useful information on a screen for a user to review while the monitor is in use.
  • the tools provide useful information while requiring only a minimal amount memory space.
  • These data presentation tools can also be used in any retrospective analysis package, such as software running on a computer or network designed to analyze trends and provide advise regarding a treatment regime.
  • the tools operate by processing that compares actual reading to high and low value limits (e.g., but not limited to, acceptable blood glucose ranges).
  • the limits can be the adjustable hypoglycemic and hyperglycemic alarm thresholds of a monitor.
  • the tools can be applied to a fixed definition of a target blood glucose range that is independent of the hyperglycemic and hypoglycemic alarm thresholds for the particular user/monitor.
  • FIG. 6A illustrates one minimum and maximum data presentation.
  • a display of the minimum and maximum values 600 of the characteristic monitor that have been measured for the user can be displayed on the monitor.
  • the minimum value and maximum values can be conveniently displayed along with the date and time of their occurrence.
  • Such a display 600 is useful, but becomes more useful when combined with an excursion count, a distribution of values, and/or integrated values as discussed below
  • FIG. 6B illustrates an excursion data presentation.
  • the number of excursions above or below the respective blood glucose limits is also very useful to have summarized for the user.
  • An excursion display 602 provides good information, particularly when there are no alarms active on the monitor (either because the monitor is not turned on or alarms are not being employed by the user).
  • a display 602 of the number of excursions above the hyperglycemic limit and the number of excursions below hypoglycemic limit give the user an idea of performance of a treatment program at a glance. A high number of incidents exceeding either limit indicate a need for improvements.
  • FIG. 6C illustrates a characteristic value distribution data presentation.
  • a simple distribution of sensor values offers a very powerful tool.
  • the distribution is described in percentages that are automatically scaled with the duration of monitor use.
  • a monitor can include the total time of use with a percentage distribution. Awareness of a total time provides perspective for reviewing the percentage distribution.
  • a time based distribution can also be used, but requires the total time to be included in the analysis as a reference.
  • a distribution can also be presented based upon the total number of readings, but requires the total time is required in the analysis.
  • the display can show a percentage of readings above a hyperglycemic alarm level, a percentage of readings below a hypoglycemic alarm level and a percentage of readings of readings within alarm range as shown in FIG. 6C .
  • the total time covered in the analysis can also be displayed.
  • an alternate display can show the time spent above a hyperglycemic alarm level, the time spent below a hypoglycemic alarm level and the time spent within alarm range (not shown).
  • the time base display requires a known total time as part of the analysis.
  • a display can also include the number of readings above hyperglycemic alarm level, the number of readings below a hypoglycemic alarm level and the number of readings within alarm range (not shown).
  • FIG. 6D illustrates an integrated characteristic value data presentation. Performing an integration of the readings outside the alarm levels with respect to time can provide a measure of the hypoglycemic and hyperglycemic events' severity. In addition, these results can also be scaled these by a total sensor time to provide a measure that is duration independent.
  • a “hyperglycemic area” can be calculated as the sum of the differences between the readings and the hyperglycemic alarm limit.
  • a “hypoglycemic area” can be calculated from the sum of all the differences between the hypoglycemic alarm limit and the readings.
  • a “hyperglycemic index” is calculated by taking the “hyperglycemic area” and dividing it by the duration of sensor use. Similarly, the “hypoglycemic index” can be calculated by taking the “hypoglycemic area” divided by the duration of sensor use.
  • a physiological characteristic monitor 104 is used for reviewing a history of measurements of the sensed characteristic value based on user input from an input device with a display for showing the history of the measurements of the sensed characteristic value.
  • the display may show the measurements only within a specified range, such as the operational range of the sensor (e.g. 40 to 400 or 20 to 600 mg/dl). Outside the specified range, a HI or LO indicator is shown.
  • FIG. 7 illustrates the real-time and history display 700 of an embodiment of the invention.
  • Three exemplary screens 702 , 704 , 706 are shown for the display of real-time or historical measurement data.
  • the in-range screen 702 is used when the measurement is within the specified range; the actual measurement is shown.
  • the high screen 704 (showing a HI indicator) is used when the measurement is above the specified range, and the low screen 706 (showing a LO indicator) is used when the measurement is below the specified range.
  • the display shows a no measurement indicator where no value was recorded in the history.
  • the user input also directs scrolling through a history of the measurements of the sensed characteristic value.
  • the display shows a single measurement at a time.
  • the display shows a time of acquisition by the sensor for each measurement in the history.
  • the current measurement is being shown, indicated by the “NOW” indicator.
  • the time of acquisition can be shown as a value relative to a most recent measurement of the history.
  • the high and low screens 704 , 706 each show values measured 5 hours and 25 minutes before the current time interval. Alternatively, the actual date and time of the measurement may be shown.
  • the history of the measurements of the sensed characteristic value can be scrolled through in even time increments.
  • the even time increment can have a selectable size (e.g. selectable between 5 minute or 30 minute increments), and the selected time increment can be indicated on the display as the history is reviewed.
  • the history itself can comprise a fixed total period from the present backward. For convenience, scrolling through the history wraps around after an end of the history is reached.
  • the NOW indicator when no measurement is currently available, can be replaced by a status message indicating no calibration, noise or a missed measurement.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US10/750,080 2001-12-27 2003-12-31 System for monitoring physiological characteristics Abandoned US20050027182A1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US10/750,080 US20050027182A1 (en) 2001-12-27 2003-12-31 System for monitoring physiological characteristics
US10/860,114 US7399277B2 (en) 2001-12-27 2004-06-03 System for monitoring physiological characteristics
PCT/US2004/041985 WO2005065538A2 (en) 2003-12-31 2004-12-15 System for monitoring physiological characteristics
CA2550855A CA2550855C (en) 2003-12-31 2004-12-15 System for monitoring physiological characteristics
JP2006547123A JP2007516783A (ja) 2003-12-31 2004-12-15 生理学的特性値モニタ
AT04814197T ATE544394T1 (de) 2003-12-31 2004-12-15 System zur überwachung von physiologischen grössen
EP04814197A EP1703839B1 (de) 2003-12-31 2004-12-15 System zur überwachung von physiologischen grössen
DK04814197.2T DK1703839T3 (da) 2003-12-31 2004-12-15 Anlæg til overvågning af fysiologiske egenskaber
PCT/US2005/019106 WO2005121785A2 (en) 2001-12-27 2005-05-20 System for monitoring physiological characteristics according to the user biological state
CA2567711A CA2567711C (en) 2003-12-31 2005-05-20 System for monitoring physiological characteristics
US11/807,786 US8961416B2 (en) 2001-12-27 2007-05-30 System for monitoring physiological characteristics
US14/599,010 US10080529B2 (en) 2001-12-27 2015-01-16 System for monitoring physiological characteristics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/034,139 US7022072B2 (en) 2001-12-27 2001-12-27 System for monitoring physiological characteristics
US10/750,080 US20050027182A1 (en) 2001-12-27 2003-12-31 System for monitoring physiological characteristics

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/034,139 Continuation-In-Part US7022072B2 (en) 2001-12-27 2001-12-27 System for monitoring physiological characteristics

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/860,114 Continuation-In-Part US7399277B2 (en) 2001-12-27 2004-06-03 System for monitoring physiological characteristics
US11/807,786 Division US8961416B2 (en) 2001-12-27 2007-05-30 System for monitoring physiological characteristics

Publications (1)

Publication Number Publication Date
US20050027182A1 true US20050027182A1 (en) 2005-02-03

Family

ID=34749316

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/750,080 Abandoned US20050027182A1 (en) 2001-12-27 2003-12-31 System for monitoring physiological characteristics
US11/807,786 Active 2028-02-20 US8961416B2 (en) 2001-12-27 2007-05-30 System for monitoring physiological characteristics

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/807,786 Active 2028-02-20 US8961416B2 (en) 2001-12-27 2007-05-30 System for monitoring physiological characteristics

Country Status (7)

Country Link
US (2) US20050027182A1 (de)
EP (1) EP1703839B1 (de)
JP (1) JP2007516783A (de)
AT (1) ATE544394T1 (de)
CA (1) CA2550855C (de)
DK (1) DK1703839T3 (de)
WO (1) WO2005065538A2 (de)

Cited By (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027463A1 (en) * 2003-08-01 2005-02-03 Goode Paul V. System and methods for processing analyte sensor data
US20050043598A1 (en) * 2003-08-22 2005-02-24 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20050096511A1 (en) * 2001-12-27 2005-05-05 Fox James K. System for monitoring physiological characteristics
US20050143635A1 (en) * 2003-12-05 2005-06-30 Kamath Apurv U. Calibration techniques for a continuous analyte sensor
US20060020190A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060142651A1 (en) * 2004-07-13 2006-06-29 Mark Brister Analyte sensor
US20060258929A1 (en) * 2005-03-10 2006-11-16 Goode Paul V Jr System and methods for processing analyte sensor data for sensor calibration
US20060270923A1 (en) * 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20070032706A1 (en) * 2003-08-22 2007-02-08 Apurv Kamath Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20070149874A1 (en) * 1998-04-30 2007-06-28 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20070197889A1 (en) * 2006-02-22 2007-08-23 Mark Brister Analyte sensor
US20070208245A1 (en) * 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US20070208246A1 (en) * 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US20070208244A1 (en) * 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US20070225675A1 (en) * 2005-11-15 2007-09-27 Mark Ries Robinson Blood Analyte Determinations
US20070255347A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Inhibition of stimulation notification
US20070276209A1 (en) * 2004-04-30 2007-11-29 Fumiaki Emoto Blood-Sugar Level Measuring Device
US20080014913A1 (en) * 2006-07-12 2008-01-17 Jason Balan Cellular mobile modbus data collection
WO2008014320A2 (en) * 2006-07-26 2008-01-31 Carson Valley Research, Llc Base station for retrieving data from and programming a medical device
US20080033254A1 (en) * 2003-07-25 2008-02-07 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US20080083617A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080086042A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Analyte sensor
US20080086039A1 (en) * 2001-01-02 2008-04-10 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US20080092638A1 (en) * 2006-10-19 2008-04-24 Bayer Healthcare Llc Wireless analyte monitoring system
US20080139910A1 (en) * 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
US20080194938A1 (en) * 2004-07-13 2008-08-14 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20080197024A1 (en) * 2003-12-05 2008-08-21 Dexcom, Inc. Analyte sensor
US20080200789A1 (en) * 2006-10-04 2008-08-21 Dexcom, Inc. Analyte sensor
US20080200791A1 (en) * 2006-10-04 2008-08-21 Dexcom, Inc. Analyte sensor
US20080208025A1 (en) * 1997-03-04 2008-08-28 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20080214918A1 (en) * 2006-10-04 2008-09-04 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080220403A1 (en) * 2007-02-16 2008-09-11 Ohio University System and method for managing diabetes
US20080242961A1 (en) * 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US20080255437A1 (en) * 2007-04-14 2008-10-16 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US20080262469A1 (en) * 2004-02-26 2008-10-23 Dexcom. Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20080287765A1 (en) * 2003-11-19 2008-11-20 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20080306435A1 (en) * 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20090018424A1 (en) * 2006-10-04 2009-01-15 Dexcom, Inc. Analyte sensor
US20090030294A1 (en) * 2004-05-03 2009-01-29 Dexcom, Inc. Implantable analyte sensor
US20090036758A1 (en) * 2003-12-09 2009-02-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090036753A1 (en) * 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
US20090048535A1 (en) * 2007-08-13 2009-02-19 Mark Ries Robinson Detecting Cross-contamination in Blood Measurements with a Multilumen Catheter
US20090054754A1 (en) * 2007-08-21 2009-02-26 Mcmahon Dave Clinician-controlled semi-automated medication management
US20090088615A1 (en) * 2007-10-01 2009-04-02 Mark Ries Robinson Indwelling Fiber Optic Probe for Blood Glucose Measurements
US20090124879A1 (en) * 2004-07-13 2009-05-14 Dexcom, Inc. Transcutaneous analyte sensor
US20090124964A1 (en) * 2003-12-05 2009-05-14 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US20090131776A1 (en) * 2006-10-04 2009-05-21 Dexcom, Inc. Analyte sensor
US20090131769A1 (en) * 2006-10-04 2009-05-21 Dexcom, Inc. Analyte sensor
US20090131777A1 (en) * 2006-10-04 2009-05-21 Dexcom, Inc. Analyte sensor
US20090137887A1 (en) * 2006-10-04 2009-05-28 Dexcom, Inc. Analyte sensor
US20090156975A1 (en) * 2007-11-30 2009-06-18 Mark Ries Robinson Robust System and Methods for Blood Access
US20090192745A1 (en) * 2003-08-01 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20090192366A1 (en) * 2007-12-17 2009-07-30 Dexcom, Inc Systems and methods for processing sensor data
US20090192751A1 (en) * 2007-10-25 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20090192380A1 (en) * 2003-07-25 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20090192722A1 (en) * 2007-12-17 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20090216103A1 (en) * 2004-07-13 2009-08-27 Dexcom, Inc. Transcutaneous analyte sensor
US20090242425A1 (en) * 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US20100035334A1 (en) * 2007-12-12 2010-02-11 Eiji Okuda Biological sample measurement apparatus
US20100041971A1 (en) * 2004-05-03 2010-02-18 Dexcom, Inc. Implantable analyte sensor
US20100049024A1 (en) * 2004-01-12 2010-02-25 Dexcom, Inc. Composite material for implantable device
US20100076283A1 (en) * 2008-09-19 2010-03-25 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US20100094114A1 (en) * 2008-10-09 2010-04-15 Mark Ries Robinson Use of multiple calibration solutions with an analyte sensor with use in an automated blood access system
US20100114002A1 (en) * 2004-04-08 2010-05-06 O'mahony John J Method and apparatus for an extracorporeal control of blood glucose
US7742807B1 (en) * 2006-11-07 2010-06-22 Pacesetter, Inc. Musical representation of cardiac markers
US20100168535A1 (en) * 2006-04-12 2010-07-01 Mark Ries Robinson Methods and apparatuses related to blood analyte measurement system
US20100179409A1 (en) * 2002-02-12 2010-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100179406A1 (en) * 2003-08-01 2010-07-15 DesCom, Inc. System and methods for processing analyte sensor data
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20100259543A1 (en) * 2004-03-15 2010-10-14 E-San Ltd. Medical Data Display
US20100331654A1 (en) * 2009-06-30 2010-12-30 Lifescan Scotland Ltd. Systems for diabetes management and methods
US20100332445A1 (en) * 2009-06-30 2010-12-30 Lifescan, Inc. Analyte testing method and system
US20100332142A1 (en) * 2009-06-30 2010-12-30 Lifescan,Inc. Analyte testing method and device for calculating basal insulin therapy
US20110028815A1 (en) * 2009-07-02 2011-02-03 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US20110077493A1 (en) * 2009-09-29 2011-03-31 Lifescan Scotland Ltd. Analyte testing method and device for diabetes mangement
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US20110152642A1 (en) * 2009-12-18 2011-06-23 Mak Ries Robinson Detection of bubbles during hemodynamic monitoring when performing automated measurement of blood constituents
US20110152634A1 (en) * 2009-12-17 2011-06-23 Jeff Thew Measuring Human Biological Fluid Levels
US7976492B2 (en) 2004-02-26 2011-07-12 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8000901B2 (en) 2003-08-01 2011-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US20110205064A1 (en) * 2010-02-25 2011-08-25 Lifescan Scotland Ltd. Analyte testing method and system with high and low blood glucose trends notification
US20110231140A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20110282327A1 (en) * 2005-12-05 2011-11-17 Echo Therapeutics, Inc. System and method for continuous non-invasive glucose monitoring
US8092386B1 (en) * 2006-12-22 2012-01-10 Pacesetter, Inc. Method and implantable system for blood-glucose concentration monitoring
US8115635B2 (en) 2005-02-08 2012-02-14 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
DE102010027486A1 (de) * 2010-07-16 2012-04-12 Löser Medizintechnik GmbH Verfahren zur Überwachung des medizinischen Zustandes eines Patienten
USRE43399E1 (en) 2003-07-25 2012-05-22 Dexcom, Inc. Electrode systems for electrochemical sensors
US20120165695A1 (en) * 2009-06-26 2012-06-28 Widex A/S Eeg monitoring apparatus and method for presenting messages therein
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US20120220847A1 (en) * 2009-11-04 2012-08-30 Aimedics Pty Ltd Alarm systems using monitored physiological data and trend difference methods
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287495B2 (en) 2009-07-30 2012-10-16 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8509871B2 (en) 2001-07-27 2013-08-13 Dexcom, Inc. Sensor head for use with implantable devices
US8548553B2 (en) 2003-08-01 2013-10-01 Dexcom, Inc. System and methods for processing analyte sensor data
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US20140236536A1 (en) * 2009-07-31 2014-08-21 Abbott Diabetes Care Inc. Method and Apparatus for Providing Analyte Monitoring and Therapy Management System Accuracy
US8821433B2 (en) 2006-10-17 2014-09-02 Tandem Diabetes Care, Inc. Insulin pump having basal rate testing features
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US20140350371A1 (en) * 2008-01-07 2014-11-27 Tandem Diabetes Care, Inc. Infusion pump with blood glucose alert delay
WO2014205412A1 (en) * 2013-06-21 2014-12-24 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20150141763A1 (en) * 2013-11-18 2015-05-21 Honeywell International Inc. Non-invasive blood glucose concentration sensing using light modulation
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20150201846A1 (en) * 2012-07-24 2015-07-23 Medbright Medical Solutions Ltd Device and method for providing information indicative of a stress situation in a human
US20150208960A1 (en) * 2007-04-14 2015-07-30 Abbott Diabetes Care Inc. Method and Apparatus for Providing Data Processing and Control in Medical Communication System
US20150223763A1 (en) * 2007-12-10 2015-08-13 Bayer Healthcare Llc Interface for a health measurement and monitoring system
US9119528B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for providing sensitive and specific alarms
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20150320933A1 (en) * 2008-10-15 2015-11-12 Bigfoot Biomedical, Inc. Infusion Pump System and Methods
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US20160041537A1 (en) * 2014-08-05 2016-02-11 Siemens Industry, Inc. Enhanced alarming with bacnet objects
US9282895B2 (en) 2009-03-30 2016-03-15 Pacesetter, Inc. Method and implantable system for blood-glucose concentration monitoring using parallel methodologies
EP2184694A3 (de) * 2007-03-20 2016-05-11 Lifescan, Inc. Kommunikationsmedium für die Diabetes-Verwaltung
US9351677B2 (en) 2009-07-02 2016-05-31 Dexcom, Inc. Analyte sensor with increased reference capacity
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US9451910B2 (en) 2007-09-13 2016-09-27 Dexcom, Inc. Transcutaneous analyte sensor
US9474856B2 (en) 2007-05-24 2016-10-25 Tandem Diabetes Care, Inc. Expert system for infusion pump therapy
US20170035969A1 (en) * 2009-05-22 2017-02-09 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9833177B2 (en) 2007-05-30 2017-12-05 Tandem Diabetes Care, Inc. Insulin pump based expert system
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US9833181B2 (en) 2006-08-09 2017-12-05 Abbot Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US20170347971A1 (en) * 2016-05-02 2017-12-07 Dexcom, Inc. System and method for providing alerts optimized for a user
US9839384B2 (en) 2005-09-30 2017-12-12 Intuity Medical, Inc. Body fluid sampling arrangements
US9867937B2 (en) 2013-09-06 2018-01-16 Tandem Diabetes Care, Inc. System and method for mitigating risk in automated medicament dosing
US9897610B2 (en) 2009-11-30 2018-02-20 Intuity Medical, Inc. Calibration material delivery devices and methods
US20180103881A1 (en) * 2016-10-19 2018-04-19 Samsung Electronics Co., Ltd. Electronic apparatus and method for providing blood sugar care service
US9962486B2 (en) 2013-03-14 2018-05-08 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9995779B2 (en) 2012-11-01 2018-06-12 Terumo Kabushiki Kaisha Sensing device and sensing method
US10010291B2 (en) 2013-03-15 2018-07-03 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US10016559B2 (en) 2009-12-04 2018-07-10 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US10019554B2 (en) 2012-12-31 2018-07-10 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose
US10031002B2 (en) 2007-05-14 2018-07-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10045739B2 (en) 2008-09-30 2018-08-14 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US10119956B2 (en) 2007-05-14 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10143409B2 (en) 2007-05-14 2018-12-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
USRE47244E1 (en) * 2008-07-29 2019-02-19 Masimo Corporation Alarm suspend system
US10258736B2 (en) 2012-05-17 2019-04-16 Tandem Diabetes Care, Inc. Systems including vial adapter for fluid transfer
US10261069B2 (en) 2007-05-14 2019-04-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US10327682B2 (en) 2008-05-30 2019-06-25 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US10342469B2 (en) 2006-10-02 2019-07-09 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
US10463288B2 (en) 2008-03-28 2019-11-05 Abbott Diabetes Care Inc. Analyte sensor calibration management
US10463310B2 (en) 2007-05-14 2019-11-05 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
USRE47882E1 (en) 2010-03-01 2020-03-03 Masimo Corporation Adaptive alarm system
US10617823B2 (en) 2007-02-15 2020-04-14 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10653835B2 (en) 2007-10-09 2020-05-19 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US10772572B2 (en) 2009-08-31 2020-09-15 Abbott Diabetes Care Inc. Displays for a medical device
US20200314182A1 (en) * 2019-03-29 2020-10-01 Bionime Corporation Method and system for data transmission between a sensor device and an electronic device
US10827954B2 (en) 2009-07-23 2020-11-10 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
CN112017778A (zh) * 2020-08-06 2020-12-01 东北大学 一种面向临床的多层级血糖异常预警方法
US10856785B2 (en) 2007-06-29 2020-12-08 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US20200405224A1 (en) * 2009-06-17 2020-12-31 Medtronic Minimed, Inc. Closed-loop glucose and/or insulin control system
US10932672B2 (en) * 2015-12-28 2021-03-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US10939859B2 (en) 2011-11-23 2021-03-09 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10991456B2 (en) 2007-05-14 2021-04-27 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11076785B2 (en) 2007-05-14 2021-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11109757B2 (en) 2012-12-31 2021-09-07 Dexcom, Inc. Remote monitoring of analyte measurements
US11224693B2 (en) 2018-10-10 2022-01-18 Tandem Diabetes Care, Inc. System and method for switching between medicament delivery control algorithms
US11291763B2 (en) 2007-03-13 2022-04-05 Tandem Diabetes Care, Inc. Basal rate testing using frequent blood glucose input
US11312298B2 (en) * 2020-01-30 2022-04-26 International Business Machines Corporation Modulating attention of responsible parties to predicted dangers of self-driving cars
EP3764956B1 (de) 2018-03-15 2022-05-11 Coloplast A/S Verfahren zur verwaltung der resttragezeit einer stomavorrichtung und zugehörige zubehörgeräte
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11331051B2 (en) 2012-12-31 2022-05-17 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US11355238B2 (en) * 2006-01-05 2022-06-07 University Of Virginia Patent Foundation Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US11553860B2 (en) 2008-06-06 2023-01-17 Intuity Medical, Inc. Medical diagnostic devices and methods
US11559260B2 (en) 2003-08-22 2023-01-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11676694B2 (en) 2012-06-07 2023-06-13 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US11723560B2 (en) 2018-02-09 2023-08-15 Dexcom, Inc. System and method for decision support
US11735295B2 (en) 2008-05-30 2023-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US11883163B1 (en) * 2018-01-17 2024-01-30 Verily Life Sciences Llc Investigation of glycemic events in blood glucose
US11896371B2 (en) 2012-09-26 2024-02-13 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US12059268B1 (en) 2019-04-30 2024-08-13 Verily Life Sciences Llc Managing meal excursions in blood glucose data

Families Citing this family (231)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080529B2 (en) 2001-12-27 2018-09-25 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US20050027182A1 (en) 2001-12-27 2005-02-03 Uzair Siddiqui System for monitoring physiological characteristics
US6850788B2 (en) 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US7679407B2 (en) 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US8961461B2 (en) 2004-05-27 2015-02-24 Baxter International Inc. Multi-state alarm system for a medical pump
DK2259057T3 (en) * 2004-06-03 2016-05-09 Medtronic Minimed Inc System for monitoring physical characteristics depending on the user's physical condition
CA3090413C (en) 2004-06-04 2023-10-10 Abbott Diabetes Care Inc. Glucose monitoring and graphical representations in a data management system
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
JP2008544214A (ja) 2005-05-09 2008-12-04 セラノス， インコーポレイテッド ポイントオブケア流体システムおよびその使用
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
WO2007027691A1 (en) 2005-08-31 2007-03-08 University Of Virginia Patent Foundation Improving the accuracy of continuous glucose sensors
US7583190B2 (en) 2005-10-31 2009-09-01 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
JP2009532768A (ja) * 2006-03-23 2009-09-10 ベクトン・ディキンソン・アンド・カンパニー 改良された糖尿病データ管理のためのシステムおよび方法、および使用法
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US20070255126A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Data communication in networked fluid infusion systems
US8073008B2 (en) 2006-04-28 2011-12-06 Medtronic Minimed, Inc. Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network
US7942844B2 (en) 2006-04-28 2011-05-17 Medtronic Minimed, Inc. Remote monitoring for networked fluid infusion systems
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
US7647202B2 (en) * 2006-07-05 2010-01-12 Arizona Public Service Company Method for exception-based notification of the condition of an apparatus
JP4853207B2 (ja) * 2006-09-28 2012-01-11 ニプロ株式会社 血糖測定装置
JP4894439B2 (ja) * 2006-09-28 2012-03-14 ニプロ株式会社 血糖測定装置
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8948868B2 (en) * 2006-10-31 2015-02-03 Medtronic, Inc. Methods and apparatus for manually suspending intrathoracic impedance fluid status measurements
US20080113391A1 (en) 2006-11-14 2008-05-15 Ian Gibbons Detection and quantification of analytes in bodily fluids
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
DK2134251T3 (en) * 2007-03-12 2014-11-24 Bayer Healthcare Llc Method for use of a measure that is to simultaneously displaying the number of high, low and total test results
US8758245B2 (en) * 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
JP2008253560A (ja) * 2007-04-05 2008-10-23 Shinichi Yoshida 擬似低血糖検知・警報発信装置
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
ES2784736T3 (es) 2007-04-14 2020-09-30 Abbott Diabetes Care Inc Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
ES2681895T3 (es) 2007-06-18 2018-09-17 F. Hoffmann-La Roche Ag Método y sistema de control de la glucosa para monitorizar la respuesta metabólica individual y para generar una respuesta nutricional
EP2166928B1 (de) 2007-06-21 2018-09-12 Abbott Diabetes Care Inc. Gesundheitsmonitor
JP5680960B2 (ja) 2007-06-21 2015-03-04 アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． 健康管理装置および方法
US9754078B2 (en) * 2007-06-21 2017-09-05 Immersion Corporation Haptic health feedback monitoring
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US20090054736A1 (en) * 2007-08-23 2009-02-26 General Electric Company Method and system for a patient monitoring alarm
CA3138078C (en) 2007-10-02 2024-02-13 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US8313467B2 (en) 2007-12-27 2012-11-20 Medtronic Minimed, Inc. Reservoir pressure equalization systems and methods
US7826382B2 (en) * 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
KR20140117698A (ko) * 2008-07-07 2014-10-07 아가매트릭스, 인코포레이티드 통합 혈당 측정 장치
EP2345893B1 (de) 2008-11-04 2016-05-04 Panasonic Healthcare Holdings Co., Ltd. Messvorrichtung, messverfahren, und programm
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US10032002B2 (en) 2009-03-04 2018-07-24 Masimo Corporation Medical monitoring system
US10007758B2 (en) 2009-03-04 2018-06-26 Masimo Corporation Medical monitoring system
US9218454B2 (en) 2009-03-04 2015-12-22 Masimo Corporation Medical monitoring system
US20100249965A1 (en) * 2009-03-31 2010-09-30 Agamatrix, Inc. Integrated Blood Glucose Measurement Device
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
EP2419015A4 (de) * 2009-04-16 2014-08-20 Abbott Diabetes Care Inc Kalibrierung eines analytsensors
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
EP2424426B1 (de) 2009-04-29 2020-01-08 Abbott Diabetes Care, Inc. Verfahren und system zur datenübertragung in einem system für kontinuierliche glucoseüberwachung und glucosemanagement
EP2425209A4 (de) 2009-04-29 2013-01-09 Abbott Diabetes Care Inc Verfahren und system für die echtzeit-kalibrierung eines analytsensors mit rückwirkender füllung
US9579456B2 (en) 2009-05-22 2017-02-28 Abbott Diabetes Care Inc. Methods for reducing false hypoglycemia alarm occurrence
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
WO2010141922A1 (en) 2009-06-04 2010-12-09 Abbott Diabetes Care Inc. Method and system for updating a medical device
US8344847B2 (en) 2009-07-09 2013-01-01 Medtronic Minimed, Inc. Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
CN105686807B (zh) 2009-08-31 2019-11-15 雅培糖尿病护理公司 医疗设备
US8487758B2 (en) 2009-09-02 2013-07-16 Medtronic Minimed, Inc. Medical device having an intelligent alerting scheme, and related operating methods
NZ599873A (en) 2009-10-19 2014-09-26 Theranos Inc Integrated health data capture and analysis system
WO2011053881A1 (en) 2009-10-30 2011-05-05 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8386042B2 (en) 2009-11-03 2013-02-26 Medtronic Minimed, Inc. Omnidirectional accelerometer device and medical device incorporating same
US8574201B2 (en) 2009-12-22 2013-11-05 Medtronic Minimed, Inc. Syringe piston with check valve seal
US8755269B2 (en) 2009-12-23 2014-06-17 Medtronic Minimed, Inc. Ranking and switching of wireless channels in a body area network of medical devices
KR20120123444A (ko) * 2010-01-22 2012-11-08 라이프스캔, 인코포레이티드 분석물 검사 방법 및 시스템
CN102883656A (zh) * 2010-03-31 2013-01-16 安尼马斯公司 用于显示分析物传感器数据的方法和系统
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
WO2012048168A2 (en) 2010-10-07 2012-04-12 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US8603033B2 (en) 2010-10-15 2013-12-10 Medtronic Minimed, Inc. Medical device and related assembly having an offset element for a piezoelectric speaker
US8562565B2 (en) 2010-10-15 2013-10-22 Medtronic Minimed, Inc. Battery shock absorber for a portable medical device
US8603032B2 (en) 2010-10-15 2013-12-10 Medtronic Minimed, Inc. Medical device with membrane keypad sealing element, and related manufacturing method
US8474332B2 (en) 2010-10-20 2013-07-02 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8495918B2 (en) 2010-10-20 2013-07-30 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8479595B2 (en) 2010-10-20 2013-07-09 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8690855B2 (en) 2010-12-22 2014-04-08 Medtronic Minimed, Inc. Fluid reservoir seating procedure for a fluid infusion device
US8628510B2 (en) 2010-12-22 2014-01-14 Medtronic Minimed, Inc. Monitoring the operating health of a force sensor in a fluid infusion device
US8469942B2 (en) 2010-12-22 2013-06-25 Medtronic Minimed, Inc. Occlusion detection for a fluid infusion device
US8197444B1 (en) 2010-12-22 2012-06-12 Medtronic Minimed, Inc. Monitoring the seating status of a fluid reservoir in a fluid infusion device
CN106290160A (zh) 2011-01-21 2017-01-04 提拉诺斯公司 样品使用最大化的系统和方法
US9463309B2 (en) 2011-02-22 2016-10-11 Medtronic Minimed, Inc. Sealing assembly and structure for a fluid infusion device having a needled fluid reservoir
US9283318B2 (en) 2011-02-22 2016-03-15 Medtronic Minimed, Inc. Flanged sealing element and needle guide pin assembly for a fluid infusion device having a needled fluid reservoir
US8900206B2 (en) 2011-02-22 2014-12-02 Medtronic Minimed, Inc. Pressure vented fluid reservoir for a fluid infusion device
US9393399B2 (en) 2011-02-22 2016-07-19 Medtronic Minimed, Inc. Sealing assembly for a fluid reservoir of a fluid infusion device
EP2680754B1 (de) 2011-02-28 2019-04-24 Abbott Diabetes Care, Inc. Vorrichtungen, systeme und verfahren im zusammenhang mit analytüberwachungsvorrichtungen und vorrichtungen damit
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US8614596B2 (en) 2011-02-28 2013-12-24 Medtronic Minimed, Inc. Systems and methods for initializing a voltage bus and medical devices incorporating same
US9101305B2 (en) 2011-03-09 2015-08-11 Medtronic Minimed, Inc. Glucose sensor product and related manufacturing and packaging methods
US9018893B2 (en) 2011-03-18 2015-04-28 Medtronic Minimed, Inc. Power control techniques for an electronic device
US8564447B2 (en) 2011-03-18 2013-10-22 Medtronic Minimed, Inc. Battery life indication techniques for an electronic device
EP2696746B1 (de) 2011-04-14 2017-06-14 Koninklijke Philips N.V. Gestuftes alarmverfahren für patientenmonitore
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
CA2840640C (en) 2011-11-07 2020-03-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9610401B2 (en) 2012-01-13 2017-04-04 Medtronic Minimed, Inc. Infusion set component with modular fluid channel element
US8523803B1 (en) 2012-03-20 2013-09-03 Medtronic Minimed, Inc. Motor health monitoring and medical device incorporating same
US8603027B2 (en) 2012-03-20 2013-12-10 Medtronic Minimed, Inc. Occlusion detection using pulse-width modulation and medical device incorporating same
US8603026B2 (en) 2012-03-20 2013-12-10 Medtronic Minimed, Inc. Dynamic pulse-width modulation motor control and medical device incorporating same
US10391242B2 (en) 2012-06-07 2019-08-27 Medtronic Minimed, Inc. Diabetes therapy management system for recommending bolus calculator adjustments
US9333292B2 (en) 2012-06-26 2016-05-10 Medtronic Minimed, Inc. Mechanically actuated fluid infusion device
US8808269B2 (en) 2012-08-21 2014-08-19 Medtronic Minimed, Inc. Reservoir plunger position monitoring and medical device incorporating same
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9849239B2 (en) 2012-08-30 2017-12-26 Medtronic Minimed, Inc. Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system
US9623179B2 (en) 2012-08-30 2017-04-18 Medtronic Minimed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
US20140066884A1 (en) 2012-08-30 2014-03-06 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US8870818B2 (en) 2012-11-15 2014-10-28 Medtronic Minimed, Inc. Systems and methods for alignment and detection of a consumable component
US9107994B2 (en) 2013-01-18 2015-08-18 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9522223B2 (en) 2013-01-18 2016-12-20 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9033924B2 (en) 2013-01-18 2015-05-19 Medtronic Minimed, Inc. Systems for fluid reservoir retention
EP2762066A1 (de) 2013-02-05 2014-08-06 Koninklijke Philips N.V. Verfahren und Gerät zur Bestimmung Vitalparamterinformation
US9308321B2 (en) 2013-02-18 2016-04-12 Medtronic Minimed, Inc. Infusion device having gear assembly initialization
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US8920381B2 (en) 2013-04-12 2014-12-30 Medtronic Minimed, Inc. Infusion set with improved bore configuration
US9433731B2 (en) 2013-07-19 2016-09-06 Medtronic Minimed, Inc. Detecting unintentional motor motion and infusion device incorporating same
US9402949B2 (en) 2013-08-13 2016-08-02 Medtronic Minimed, Inc. Detecting conditions associated with medical device operations using matched filters
US9880528B2 (en) 2013-08-21 2018-01-30 Medtronic Minimed, Inc. Medical devices and related updating methods and systems
US9889257B2 (en) 2013-08-21 2018-02-13 Medtronic Minimed, Inc. Systems and methods for updating medical devices
US9259528B2 (en) 2013-08-22 2016-02-16 Medtronic Minimed, Inc. Fluid infusion device with safety coupling
US9750877B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Predicted time to assess and/or control a glycemic state
US9750878B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Closed-loop control of glucose according to a predicted blood glucose trajectory
US9849240B2 (en) 2013-12-12 2017-12-26 Medtronic Minimed, Inc. Data modification for predictive operations and devices incorporating same
US10105488B2 (en) 2013-12-12 2018-10-23 Medtronic Minimed, Inc. Predictive infusion device operations and related methods and systems
US9694132B2 (en) 2013-12-19 2017-07-04 Medtronic Minimed, Inc. Insertion device for insertion set
WO2015102745A1 (en) 2013-12-31 2015-07-09 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
BR112016015549A2 (pt) * 2014-01-06 2017-08-08 Koninklijke Philips Nv Sistema de monitoramento médico, método para ajustar alarmes médicos, mídia de armazenamento legível por computador não transitória, e, dispositivo de processamento de dados eletrônicos
US9399096B2 (en) 2014-02-06 2016-07-26 Medtronic Minimed, Inc. Automatic closed-loop control adjustments and infusion systems incorporating same
US9861748B2 (en) 2014-02-06 2018-01-09 Medtronic Minimed, Inc. User-configurable closed-loop notifications and infusion systems incorporating same
US9987422B2 (en) 2014-03-24 2018-06-05 Medtronic Minimed, Inc. Fluid infusion patch pump device with automatic startup feature
WO2015153482A1 (en) 2014-03-30 2015-10-08 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US20150289823A1 (en) * 2014-04-10 2015-10-15 Dexcom, Inc. Glycemic urgency assessment and alerts interface
US10001450B2 (en) 2014-04-18 2018-06-19 Medtronic Minimed, Inc. Nonlinear mapping technique for a physiological characteristic sensor
US10232113B2 (en) 2014-04-24 2019-03-19 Medtronic Minimed, Inc. Infusion devices and related methods and systems for regulating insulin on board
US10275572B2 (en) 2014-05-01 2019-04-30 Medtronic Minimed, Inc. Detecting blockage of a reservoir cavity during a seating operation of a fluid infusion device
US9681828B2 (en) 2014-05-01 2017-06-20 Medtronic Minimed, Inc. Physiological characteristic sensors and methods for forming such sensors
US10152049B2 (en) 2014-05-19 2018-12-11 Medtronic Minimed, Inc. Glucose sensor health monitoring and related methods and systems
US10007765B2 (en) 2014-05-19 2018-06-26 Medtronic Minimed, Inc. Adaptive signal processing for infusion devices and related methods and systems
US10274349B2 (en) 2014-05-19 2019-04-30 Medtronic Minimed, Inc. Calibration factor adjustments for infusion devices and related methods and systems
US9833563B2 (en) 2014-09-26 2017-12-05 Medtronic Minimed, Inc. Systems for managing reservoir chamber pressure
US9839753B2 (en) 2014-09-26 2017-12-12 Medtronic Minimed, Inc. Systems for managing reservoir chamber pressure
US10279126B2 (en) 2014-10-07 2019-05-07 Medtronic Minimed, Inc. Fluid conduit assembly with gas trapping filter in the fluid flow path
US9833564B2 (en) 2014-11-25 2017-12-05 Medtronic Minimed, Inc. Fluid conduit assembly with air venting features
US10195341B2 (en) 2014-11-26 2019-02-05 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
US9987420B2 (en) 2014-11-26 2018-06-05 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
US9943645B2 (en) 2014-12-04 2018-04-17 Medtronic Minimed, Inc. Methods for operating mode transitions and related infusion devices and systems
US9636453B2 (en) 2014-12-04 2017-05-02 Medtronic Minimed, Inc. Advance diagnosis of infusion device operating mode viability
US9937292B2 (en) 2014-12-09 2018-04-10 Medtronic Minimed, Inc. Systems for filling a fluid infusion device reservoir
US10265031B2 (en) 2014-12-19 2019-04-23 Medtronic Minimed, Inc. Infusion devices and related methods and systems for automatic alert clearing
US10307535B2 (en) 2014-12-19 2019-06-04 Medtronic Minimed, Inc. Infusion devices and related methods and systems for preemptive alerting
US10307528B2 (en) 2015-03-09 2019-06-04 Medtronic Minimed, Inc. Extensible infusion devices and related methods
US10449298B2 (en) 2015-03-26 2019-10-22 Medtronic Minimed, Inc. Fluid injection devices and related methods
US10137243B2 (en) 2015-05-26 2018-11-27 Medtronic Minimed, Inc. Infusion devices with distributed motor control and related operating methods
US9999721B2 (en) 2015-05-26 2018-06-19 Medtronic Minimed, Inc. Error handling in infusion devices with distributed motor control and related operating methods
US10575767B2 (en) 2015-05-29 2020-03-03 Medtronic Minimed, Inc. Method for monitoring an analyte, analyte sensor and analyte monitoring apparatus
US9987425B2 (en) 2015-06-22 2018-06-05 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and sensor contact elements
US9879668B2 (en) 2015-06-22 2018-01-30 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and an optical sensor
US9878095B2 (en) 2015-06-22 2018-01-30 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and multiple sensor contact elements
US10010668B2 (en) 2015-06-22 2018-07-03 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and a force sensor
US9993594B2 (en) 2015-06-22 2018-06-12 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and rotor position sensors
US10293108B2 (en) 2015-08-21 2019-05-21 Medtronic Minimed, Inc. Infusion devices and related patient ratio adjustment methods
US10664569B2 (en) 2015-08-21 2020-05-26 Medtronic Minimed, Inc. Data analytics and generation of recommendations for controlling glycemic outcomes associated with tracked events
US10478557B2 (en) 2015-08-21 2019-11-19 Medtronic Minimed, Inc. Personalized parameter modeling methods and related devices and systems
US10463297B2 (en) 2015-08-21 2019-11-05 Medtronic Minimed, Inc. Personalized event detection methods and related devices and systems
US10201657B2 (en) 2015-08-21 2019-02-12 Medtronic Minimed, Inc. Methods for providing sensor site rotation feedback and related infusion devices and systems
US10117992B2 (en) 2015-09-29 2018-11-06 Medtronic Minimed, Inc. Infusion devices and related rescue detection methods
US11666702B2 (en) 2015-10-19 2023-06-06 Medtronic Minimed, Inc. Medical devices and related event pattern treatment recommendation methods
US11501867B2 (en) 2015-10-19 2022-11-15 Medtronic Minimed, Inc. Medical devices and related event pattern presentation methods
US10146911B2 (en) 2015-10-23 2018-12-04 Medtronic Minimed, Inc. Medical devices and related methods and systems for data transfer
US10037722B2 (en) 2015-11-03 2018-07-31 Medtronic Minimed, Inc. Detecting breakage in a display element
US10449306B2 (en) 2015-11-25 2019-10-22 Medtronics Minimed, Inc. Systems for fluid delivery with wicking membrane
US10589038B2 (en) 2016-04-27 2020-03-17 Medtronic Minimed, Inc. Set connector systems for venting a fluid reservoir
US11097051B2 (en) 2016-11-04 2021-08-24 Medtronic Minimed, Inc. Methods and apparatus for detecting and reacting to insufficient hypoglycemia response
US20180150614A1 (en) 2016-11-28 2018-05-31 Medtronic Minimed, Inc. Interactive patient guidance for medical devices
EP3329847A1 (de) 2016-11-30 2018-06-06 Inreda Diabetic B.V. Vorrichtung zur regelung der konzentration von glucose im blut eines menschen
US10238030B2 (en) 2016-12-06 2019-03-26 Medtronic Minimed, Inc. Wireless medical device with a complementary split ring resonator arrangement for suppression of electromagnetic interference
US10272201B2 (en) 2016-12-22 2019-04-30 Medtronic Minimed, Inc. Insertion site monitoring methods and related infusion devices and systems
US10500135B2 (en) 2017-01-30 2019-12-10 Medtronic Minimed, Inc. Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device
US10532165B2 (en) 2017-01-30 2020-01-14 Medtronic Minimed, Inc. Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device
US10552580B2 (en) 2017-02-07 2020-02-04 Medtronic Minimed, Inc. Infusion system consumables and related calibration methods
US10363365B2 (en) 2017-02-07 2019-07-30 Medtronic Minimed, Inc. Infusion devices and related consumable calibration methods
US10646649B2 (en) 2017-02-21 2020-05-12 Medtronic Minimed, Inc. Infusion devices and fluid identification apparatuses and methods
US11207463B2 (en) 2017-02-21 2021-12-28 Medtronic Minimed, Inc. Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device
WO2018204568A1 (en) 2017-05-05 2018-11-08 Eli Lilly And Company Closed loop control of physiological glucose
WO2019125932A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
EP3545824B1 (de) * 2018-03-26 2022-07-20 Sony Group Corporation Verfahren zur unterstützung eines benutzers und benutzervorrichtung
WO2019246381A1 (en) 2018-06-22 2019-12-26 Eli Lilly And Company Insulin and pramlintide delivery systems, methods, and devices
JP6581321B1 (ja) * 2019-05-10 2019-09-25 フクダ電子株式会社 生体情報モニタ装置、生体情報モニタ装置のアラーム制御方法、及び生体情報モニタ装置のアラーム制御プログラム
JP7291589B2 (ja) * 2019-09-25 2023-06-15 フクダ電子株式会社 生体情報モニタ装置、生体情報モニタ装置のアラーム制御方法、及び生体情報モニタ装置のアラーム制御プログラム
CN115066203A (zh) 2020-01-13 2022-09-16 梅西莫股份有限公司 具有生理参数监测的可穿戴设备

Citations (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US566063A (en) * 1896-08-18 Thomas curley
US3701345A (en) * 1970-09-29 1972-10-31 Medrad Inc Angiographic injector equipment
US4385272A (en) * 1980-12-24 1983-05-24 Whitehead Gary J Cable checker utilizing logic circuitry
US4498479A (en) * 1981-06-24 1985-02-12 Kone Oy Electrocardiograph (ECG) electrode testing system
US4510346A (en) * 1983-09-30 1985-04-09 At&T Bell Laboratories Shielded cable
US4562751A (en) * 1984-01-06 1986-01-07 Nason Clyde K Solenoid drive apparatus for an external infusion pump
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4619646A (en) * 1984-01-25 1986-10-28 Fernandez Tresguerres Hernande Device for the delivery-dosing of injectable products
US4676568A (en) * 1986-02-21 1987-06-30 Adc Telecommunications, Inc. Terminal test plug
US4678406A (en) * 1986-04-25 1987-07-07 Frick Company Variable volume ratio screw compressor with step control
US4685903A (en) * 1984-01-06 1987-08-11 Pacesetter Infusion, Ltd. External infusion pump apparatus
US4731726A (en) * 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4747824A (en) * 1986-05-30 1988-05-31 Spinello Ronald P Hypodermic anesthetic injection method
US4760730A (en) * 1987-07-14 1988-08-02 Medex, Inc. Calibration system for blood pressure transducer
US4857857A (en) * 1988-11-23 1989-08-15 The Research Foundation Of State University Of New York Electrode catheter testing device
US5080653A (en) * 1990-04-16 1992-01-14 Pacesetter Infusion, Ltd. Infusion pump with dual position syringe locator
US5097122A (en) * 1990-04-16 1992-03-17 Pacesetter Infusion, Ltd. Medication infusion system having optical motion sensor to detect drive mechanism malfunction
US5124661A (en) * 1990-07-23 1992-06-23 I-Stat Corporation Reusable test unit for simulating electrochemical sensor signals for quality assurance of portable blood analyzer instruments
US5219099A (en) * 1991-09-06 1993-06-15 California Institute Of Technology Coaxial lead screw drive syringe pump
US5233986A (en) * 1992-04-10 1993-08-10 Random Technologies, Inc. Time domain reflectometer-integrity testing system and method for medical device electrode
US5376070A (en) * 1992-09-29 1994-12-27 Minimed Inc. Data transfer system for an infusion pump
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5414213A (en) * 1992-10-21 1995-05-09 Hillburn; Ralph D. Shielded electric cable
US5482473A (en) * 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5523534A (en) * 1993-06-28 1996-06-04 Vital Connections, Inc. Shielded carbon lead for medical electrodes
US5557210A (en) * 1992-11-20 1996-09-17 Pacesetter, Inc. Universal cable connector for temporarily connecting implantable stimulation leads and implantable stimulation devices with a non-implantable system analyzer
US5569186A (en) * 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5586553A (en) * 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US5683270A (en) * 1994-02-10 1997-11-04 W.W. Fischer Sa Electrical plug-type connector, particularly for medical technology
US5781024A (en) * 1996-07-26 1998-07-14 Diametrics Medical, Inc. Instrument performance verification system
US5792068A (en) * 1992-06-23 1998-08-11 Edentec, Inc. Medical monitor with failure protection
US5822715A (en) * 1997-01-10 1998-10-13 Health Hero Network Diabetes management system and method for controlling blood glucose
US5824959A (en) * 1995-11-02 1998-10-20 Karl Mayer Textilmachinenfabrik Gmbh Flexible electrical cable and associated apparatus
US5834699A (en) * 1996-02-21 1998-11-10 The Whitaker Corporation Cable with spaced helices
US5954643A (en) * 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
US6030346A (en) * 1996-02-21 2000-02-29 The Whitaker Corporation Ultrasound imaging probe assembly
US6113537A (en) * 1996-04-19 2000-09-05 Castano; Jaime A. Optical method and device for determining blood glucose levels
US6117083A (en) * 1996-02-21 2000-09-12 The Whitaker Corporation Ultrasound imaging probe assembly
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US20010011224A1 (en) * 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
US6551276B1 (en) * 1998-08-18 2003-04-22 Medtronic Minimed, Inc. External infusion device with remote programming bolus estimator and/or vibration alarm capabilities
US6558351B1 (en) * 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US20030211617A1 (en) * 2002-05-07 2003-11-13 International Business Machines Corporation Blood glucose meter that reminds the user to test after a hypoglycemic event
US6893396B2 (en) * 2000-03-01 2005-05-17 I-Medik, Inc. Wireless internet bio-telemetry monitoring system and interface
US7048687B1 (en) * 1999-04-14 2006-05-23 Ob Scientific, Inc. Limited use medical probe

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276888A (en) * 1978-10-26 1981-07-07 Smith Charles A Vital function monitor
US4678408A (en) 1984-01-06 1987-07-07 Pacesetter Infusion, Ltd. Solenoid drive apparatus for an external infusion pump
JPH0345241A (ja) * 1989-07-12 1991-02-26 Fukuda Denshi Co Ltd 状態表示装置及びアラーム表示方法
US5913310A (en) * 1994-05-23 1999-06-22 Health Hero Network, Inc. Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game
US5299571A (en) 1993-01-22 1994-04-05 Eli Lilly And Company Apparatus and method for implantation of sensors
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5752512A (en) 1995-05-10 1998-05-19 Massachusetts Institute Of Technology Apparatus and method for non-invasive blood analyte measurement
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US5651367A (en) * 1995-07-19 1997-07-29 Nellcor Incorporated Parameter disturbance response apparatus
US5746697A (en) * 1996-02-09 1998-05-05 Nellcor Puritan Bennett Incorporated Medical diagnostic apparatus with sleep mode
US5890929A (en) 1996-06-19 1999-04-06 Masimo Corporation Shielded medical connector
US5865736A (en) * 1997-09-30 1999-02-02 Nellcor Puritan Bennett, Inc. Method and apparatus for nuisance alarm reductions
US6579690B1 (en) 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
EP1078258B1 (de) 1998-05-13 2003-07-30 Cygnus, Inc. Vorrichtung zum vorhersagen von physiologischen messwerten
EP1115435B2 (de) 1998-09-30 2012-07-25 Medtronic MiniMed, Inc. Kommunikationsstation und - software mit einer infusionspumpe, analytenüberwachungsanlage, analytenmessgerät , oder ähnliche geräte
EP1119285A1 (de) 1998-10-08 2001-08-01 Minimed Inc. Kennzeichenmonitorsystem mit fernmessung
US6424847B1 (en) 1999-02-25 2002-07-23 Medtronic Minimed, Inc. Glucose monitor calibration methods
WO2000077659A1 (de) * 1999-06-10 2000-12-21 Koninklijke Philips Electronics N.V. Qualitätsindikator für messsignale, insbesondere medizinische messsignale wie aus der sauerstoffsättigungsmessung
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
FI115289B (fi) 2000-02-23 2005-04-15 Polar Electro Oy Elimistön energia-aineenvaihdunnan ja glukoosin määrän mittaaminen
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
KR20020072562A (ko) 2000-10-27 2002-09-16 디지털 앤젤 코포레이션 모니터링 및 추적을 위한 시스템 및 방법
DE10108861B4 (de) 2001-02-15 2005-02-03 V&M Deutschland Gmbh Einrichtung zur Herstellung eines nahtlosen Hohlkörpers mit Boden oder eines nahtlosen Rohres aus Stahl
US20030208113A1 (en) 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
US6754516B2 (en) * 2001-07-19 2004-06-22 Nellcor Puritan Bennett Incorporated Nuisance alarm reductions in a physiological monitor
US20050027182A1 (en) 2001-12-27 2005-02-03 Uzair Siddiqui System for monitoring physiological characteristics
US7022072B2 (en) * 2001-12-27 2006-04-04 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US7399277B2 (en) * 2001-12-27 2008-07-15 Medtronic Minimed, Inc. System for monitoring physiological characteristics
JP3872371B2 (ja) 2002-03-29 2007-01-24 セイコーインスツル株式会社 携帯型生体情報収集装置、生体情報収集システム及び生体情報収集方法
US7278983B2 (en) * 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US7052472B1 (en) * 2002-12-18 2006-05-30 Dsp Diabetes Sentry Products, Inc. Systems and methods for detecting symptoms of hypoglycemia
EP1601329A4 (de) * 2003-02-28 2010-08-25 Cons Res Of Richmond Inc Automatisches system zur behandlung von schlaflosigkeit

Patent Citations (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US566063A (en) * 1896-08-18 Thomas curley
US3701345A (en) * 1970-09-29 1972-10-31 Medrad Inc Angiographic injector equipment
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4385272A (en) * 1980-12-24 1983-05-24 Whitehead Gary J Cable checker utilizing logic circuitry
US4498479A (en) * 1981-06-24 1985-02-12 Kone Oy Electrocardiograph (ECG) electrode testing system
US4510346A (en) * 1983-09-30 1985-04-09 At&T Bell Laboratories Shielded cable
US4562751A (en) * 1984-01-06 1986-01-07 Nason Clyde K Solenoid drive apparatus for an external infusion pump
US4685903A (en) * 1984-01-06 1987-08-11 Pacesetter Infusion, Ltd. External infusion pump apparatus
US4619646A (en) * 1984-01-25 1986-10-28 Fernandez Tresguerres Hernande Device for the delivery-dosing of injectable products
US4676568A (en) * 1986-02-21 1987-06-30 Adc Telecommunications, Inc. Terminal test plug
US4678406A (en) * 1986-04-25 1987-07-07 Frick Company Variable volume ratio screw compressor with step control
US4731726A (en) * 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4747824A (en) * 1986-05-30 1988-05-31 Spinello Ronald P Hypodermic anesthetic injection method
US4760730A (en) * 1987-07-14 1988-08-02 Medex, Inc. Calibration system for blood pressure transducer
US4857857A (en) * 1988-11-23 1989-08-15 The Research Foundation Of State University Of New York Electrode catheter testing device
US5080653A (en) * 1990-04-16 1992-01-14 Pacesetter Infusion, Ltd. Infusion pump with dual position syringe locator
US5097122A (en) * 1990-04-16 1992-03-17 Pacesetter Infusion, Ltd. Medication infusion system having optical motion sensor to detect drive mechanism malfunction
US5124661A (en) * 1990-07-23 1992-06-23 I-Stat Corporation Reusable test unit for simulating electrochemical sensor signals for quality assurance of portable blood analyzer instruments
US5219099A (en) * 1991-09-06 1993-06-15 California Institute Of Technology Coaxial lead screw drive syringe pump
US5233986A (en) * 1992-04-10 1993-08-10 Random Technologies, Inc. Time domain reflectometer-integrity testing system and method for medical device electrode
US5792068A (en) * 1992-06-23 1998-08-11 Edentec, Inc. Medical monitor with failure protection
US5376070A (en) * 1992-09-29 1994-12-27 Minimed Inc. Data transfer system for an infusion pump
US5414213A (en) * 1992-10-21 1995-05-09 Hillburn; Ralph D. Shielded electric cable
US5557210A (en) * 1992-11-20 1996-09-17 Pacesetter, Inc. Universal cable connector for temporarily connecting implantable stimulation leads and implantable stimulation devices with a non-implantable system analyzer
US5523534A (en) * 1993-06-28 1996-06-04 Vital Connections, Inc. Shielded carbon lead for medical electrodes
US5683270A (en) * 1994-02-10 1997-11-04 W.W. Fischer Sa Electrical plug-type connector, particularly for medical technology
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5569186A (en) * 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5482473A (en) * 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5586553A (en) * 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US20010011224A1 (en) * 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
US5824959A (en) * 1995-11-02 1998-10-20 Karl Mayer Textilmachinenfabrik Gmbh Flexible electrical cable and associated apparatus
US5834699A (en) * 1996-02-21 1998-11-10 The Whitaker Corporation Cable with spaced helices
US6030346A (en) * 1996-02-21 2000-02-29 The Whitaker Corporation Ultrasound imaging probe assembly
US6117083A (en) * 1996-02-21 2000-09-12 The Whitaker Corporation Ultrasound imaging probe assembly
US6113537A (en) * 1996-04-19 2000-09-05 Castano; Jaime A. Optical method and device for determining blood glucose levels
US5781024A (en) * 1996-07-26 1998-07-14 Diametrics Medical, Inc. Instrument performance verification system
US5822715A (en) * 1997-01-10 1998-10-13 Health Hero Network Diabetes management system and method for controlling blood glucose
US5954643A (en) * 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6551276B1 (en) * 1998-08-18 2003-04-22 Medtronic Minimed, Inc. External infusion device with remote programming bolus estimator and/or vibration alarm capabilities
US7048687B1 (en) * 1999-04-14 2006-05-23 Ob Scientific, Inc. Limited use medical probe
US6558351B1 (en) * 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6893396B2 (en) * 2000-03-01 2005-05-17 I-Medik, Inc. Wireless internet bio-telemetry monitoring system and interface
US20030211617A1 (en) * 2002-05-07 2003-11-13 International Business Machines Corporation Blood glucose meter that reminds the user to test after a hypoglycemic event

Cited By (783)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208025A1 (en) * 1997-03-04 2008-08-28 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7771352B2 (en) 1997-03-04 2010-08-10 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7901354B2 (en) 1997-03-04 2011-03-08 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20080296155A1 (en) * 1997-03-04 2008-12-04 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070149874A1 (en) * 1998-04-30 2007-06-28 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070179370A1 (en) * 1998-04-30 2007-08-02 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20070191699A1 (en) * 1998-04-30 2007-08-16 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070203408A1 (en) * 1998-04-30 2007-08-30 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20070203410A1 (en) * 1998-04-30 2007-08-30 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20070203411A1 (en) * 1998-04-30 2007-08-30 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070208247A1 (en) * 1998-04-30 2007-09-06 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070249920A1 (en) * 1998-04-30 2007-10-25 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080091096A1 (en) * 1998-04-30 2008-04-17 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080086039A1 (en) * 2001-01-02 2008-04-10 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9804114B2 (en) 2001-07-27 2017-10-31 Dexcom, Inc. Sensor head for use with implantable devices
US8509871B2 (en) 2001-07-27 2013-08-13 Dexcom, Inc. Sensor head for use with implantable devices
US9328371B2 (en) 2001-07-27 2016-05-03 Dexcom, Inc. Sensor head for use with implantable devices
US20050096511A1 (en) * 2001-12-27 2005-05-05 Fox James K. System for monitoring physiological characteristics
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US20100179409A1 (en) * 2002-02-12 2010-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US20090192380A1 (en) * 2003-07-25 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20080033254A1 (en) * 2003-07-25 2008-02-07 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
USRE43399E1 (en) 2003-07-25 2012-05-22 Dexcom, Inc. Electrode systems for electrochemical sensors
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US7896809B2 (en) 2003-07-25 2011-03-01 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080194936A1 (en) * 2003-08-01 2008-08-14 Dexcom, Inc. System and methods for processing analyte sensor data
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US8052601B2 (en) 2003-08-01 2011-11-08 Dexcom, Inc. System and methods for processing analyte sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US20110231142A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20110231141A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20110231140A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US8000901B2 (en) 2003-08-01 2011-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US7986986B2 (en) 2003-08-01 2011-07-26 Dexcom, Inc. System and methods for processing analyte sensor data
US8548553B2 (en) 2003-08-01 2013-10-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20050027463A1 (en) * 2003-08-01 2005-02-03 Goode Paul V. System and methods for processing analyte sensor data
US7979104B2 (en) 2003-08-01 2011-07-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8915849B2 (en) 2003-08-01 2014-12-23 Dexcom, Inc. Transcutaneous analyte sensor
US20090192745A1 (en) * 2003-08-01 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US7959569B2 (en) 2003-08-01 2011-06-14 Dexcom, Inc. System and methods for processing analyte sensor data
US7955261B2 (en) 2003-08-01 2011-06-07 Dexcom, Inc. System and methods for processing analyte sensor data
US8986209B2 (en) 2003-08-01 2015-03-24 Dexcom, Inc. Transcutaneous analyte sensor
US8622905B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. System and methods for processing analyte sensor data
US7933639B2 (en) 2003-08-01 2011-04-26 Dexcom, Inc. System and methods for processing analyte sensor data
US7925321B2 (en) 2003-08-01 2011-04-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8808182B2 (en) 2003-08-01 2014-08-19 Dexcom, Inc. System and methods for processing analyte sensor data
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US8801612B2 (en) 2003-08-01 2014-08-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8588882B2 (en) 2003-08-01 2013-11-19 Dexcom, Inc. System and methods for processing analyte sensor data
US7914450B2 (en) 2003-08-01 2011-03-29 Dexcom, Inc. System and methods for processing analyte sensor data
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US8788006B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8788008B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8788007B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. Transcutaneous analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8771187B2 (en) 2003-08-01 2014-07-08 Dexcom, Inc. System and methods for processing analyte sensor data
US8206297B2 (en) 2003-08-01 2012-06-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20080306368A1 (en) * 2003-08-01 2008-12-11 Dexcom, Inc. System and methods for processing analyte sensor data
US8442610B2 (en) 2003-08-01 2013-05-14 Dexcom, Inc. System and methods for processing analyte sensor data
US8774888B2 (en) 2003-08-01 2014-07-08 Dexcom, Inc. System and methods for processing analyte sensor data
US20100179406A1 (en) * 2003-08-01 2010-07-15 DesCom, Inc. System and methods for processing analyte sensor data
US8428679B2 (en) 2003-08-01 2013-04-23 Dexcom, Inc. System and methods for processing analyte sensor data
US8332008B2 (en) 2003-08-01 2012-12-11 Dexcom, Inc. System and methods for processing analyte sensor data
US20100185072A1 (en) * 2003-08-01 2010-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US20100185065A1 (en) * 2003-08-01 2010-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US20080189051A1 (en) * 2003-08-01 2008-08-07 Dexcom, Inc. System and methods for processing analyte sensor data
US8285354B2 (en) 2003-08-01 2012-10-09 Dexcom, Inc. System and methods for processing analyte sensor data
US8290562B2 (en) 2003-08-01 2012-10-16 Dexcom, Inc. System and methods for processing analyte sensor data
US7778680B2 (en) 2003-08-01 2010-08-17 Dexcom, Inc. System and methods for processing analyte sensor data
US9895089B2 (en) 2003-08-01 2018-02-20 Dexcom, Inc. System and methods for processing analyte sensor data
US20100217557A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20100217106A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20100217555A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc System and methods for processing analyte sensor data
US20100214104A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc. System and methods for processing analyte sensor data
US10052055B2 (en) 2003-08-01 2018-08-21 Dexcom, Inc. Analyte sensor
US8394021B2 (en) 2003-08-01 2013-03-12 Dexcom, Inc. System and methods for processing analyte sensor data
US20070208244A1 (en) * 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US7797028B2 (en) 2003-08-01 2010-09-14 Dexcom, Inc. System and methods for processing analyte sensor data
US20070208246A1 (en) * 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US20070208245A1 (en) * 2003-08-01 2007-09-06 Brauker James H Transcutaneous analyte sensor
US10786185B2 (en) 2003-08-01 2020-09-29 Dexcom, Inc. System and methods for processing analyte sensor data
US8700117B2 (en) 2003-08-01 2014-04-15 Dexcom, Inc. System and methods for processing analyte sensor data
US7826981B2 (en) 2003-08-01 2010-11-02 Dexcom, Inc. System and methods for processing analyte sensor data
US8311749B2 (en) 2003-08-01 2012-11-13 Dexcom, Inc. Transcutaneous analyte sensor
US8321149B2 (en) 2003-08-01 2012-11-27 Dexcom, Inc. Transcutaneous analyte sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8073519B2 (en) 2003-08-22 2011-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20090124878A1 (en) * 2003-08-22 2009-05-14 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8672845B2 (en) 2003-08-22 2014-03-18 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20100240975A1 (en) * 2003-08-22 2010-09-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100240976A1 (en) * 2003-08-22 2010-09-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100235106A1 (en) * 2003-08-22 2010-09-16 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20050043598A1 (en) * 2003-08-22 2005-02-24 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8346338B2 (en) 2003-08-22 2013-01-01 Dexcom, Inc. System and methods for replacing signal artifacts in a glucose sensor data stream
US11589823B2 (en) 2003-08-22 2023-02-28 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8657747B2 (en) 2003-08-22 2014-02-25 Dexcom, Inc. Systems and methods for processing analyte sensor data
US11559260B2 (en) 2003-08-22 2023-01-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20100179408A1 (en) * 2003-08-22 2010-07-15 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8777853B2 (en) 2003-08-22 2014-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20070032706A1 (en) * 2003-08-22 2007-02-08 Apurv Kamath Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8292810B2 (en) 2003-08-22 2012-10-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8790260B2 (en) 2003-08-22 2014-07-29 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8795177B2 (en) 2003-08-22 2014-08-05 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8412301B2 (en) 2003-08-22 2013-04-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9750460B2 (en) 2003-08-22 2017-09-05 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9724045B1 (en) 2003-08-22 2017-08-08 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9649069B2 (en) 2003-08-22 2017-05-16 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9585607B2 (en) 2003-08-22 2017-03-07 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7935057B2 (en) 2003-08-22 2011-05-03 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110118579A1 (en) * 2003-08-22 2011-05-19 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110118580A1 (en) * 2003-08-22 2011-05-19 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9510782B2 (en) 2003-08-22 2016-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8812073B2 (en) 2003-08-22 2014-08-19 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110124997A1 (en) * 2003-08-22 2011-05-26 Dexcom, Inc. System and methods for replacing signal artifacts in a glucose sensor data stream
US20110130971A1 (en) * 2003-08-22 2011-06-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110130970A1 (en) * 2003-08-22 2011-06-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036225A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110137601A1 (en) * 2003-08-22 2011-06-09 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8821400B2 (en) 2003-08-22 2014-09-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036222A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036224A1 (en) * 2003-08-22 2010-02-11 DecCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036216A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036215A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036223A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100030053A1 (en) * 2003-08-22 2010-02-04 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9427183B2 (en) 2003-08-22 2016-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7998071B2 (en) 2003-08-22 2011-08-16 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8005525B2 (en) 2003-08-22 2011-08-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9420968B2 (en) 2003-08-22 2016-08-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8843187B2 (en) 2003-08-22 2014-09-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110218414A1 (en) * 2003-08-22 2011-09-08 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8233959B2 (en) 2003-08-22 2012-07-31 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8435179B2 (en) 2003-08-22 2013-05-07 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8229536B2 (en) 2003-08-22 2012-07-24 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9149219B2 (en) 2003-08-22 2015-10-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8195265B2 (en) 2003-08-22 2012-06-05 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8167801B2 (en) 2003-08-22 2012-05-01 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8073520B2 (en) 2003-08-22 2011-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20090124877A1 (en) * 2003-08-22 2009-05-14 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8491474B2 (en) 2003-08-22 2013-07-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8128562B2 (en) 2003-08-22 2012-03-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8150488B2 (en) 2003-08-22 2012-04-03 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11564602B2 (en) 2003-11-19 2023-01-31 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US9538946B2 (en) 2003-11-19 2017-01-10 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7927274B2 (en) 2003-11-19 2011-04-19 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8282550B2 (en) 2003-11-19 2012-10-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20080287765A1 (en) * 2003-11-19 2008-11-20 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20080287766A1 (en) * 2003-11-19 2008-11-20 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7917186B2 (en) 2003-12-05 2011-03-29 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20100331648A1 (en) * 2003-12-05 2010-12-30 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20050143635A1 (en) * 2003-12-05 2005-06-30 Kamath Apurv U. Calibration techniques for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20100198036A1 (en) * 2003-12-05 2010-08-05 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20100185070A1 (en) * 2003-12-05 2010-07-22 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11020031B1 (en) 2003-12-05 2021-06-01 Dexcom, Inc. Analyte sensor
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US7715893B2 (en) 2003-12-05 2010-05-11 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8386004B2 (en) 2003-12-05 2013-02-26 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8483793B2 (en) 2003-12-05 2013-07-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10299712B2 (en) 2003-12-05 2019-05-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8911369B2 (en) 2003-12-05 2014-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20090099436A1 (en) * 2003-12-05 2009-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10188333B2 (en) 2003-12-05 2019-01-29 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8929968B2 (en) 2003-12-05 2015-01-06 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
USRE44695E1 (en) 2003-12-05 2014-01-07 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8428678B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20100063373A1 (en) * 2003-12-05 2010-03-11 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8160671B2 (en) 2003-12-05 2012-04-17 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8249684B2 (en) 2003-12-05 2012-08-21 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US9579053B2 (en) 2003-12-05 2017-02-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080197024A1 (en) * 2003-12-05 2008-08-21 Dexcom, Inc. Analyte sensor
US8425417B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US20090124964A1 (en) * 2003-12-05 2009-05-14 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US20100045465A1 (en) * 2003-12-09 2010-02-25 Dexcom Inc. Signal processing for continuous analyte sensor
US20100010332A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US8265725B2 (en) 2003-12-09 2012-09-11 Dexcom, Inc. Signal processing for continuous analyte sensor
US9498155B2 (en) 2003-12-09 2016-11-22 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100030484A1 (en) * 2003-12-09 2010-02-04 Dexcom, Inc. Signal processing for continuous analyte sensor
US8251906B2 (en) 2003-12-09 2012-08-28 Dexcom, Inc. Signal processing for continuous analyte sensor
US9420965B2 (en) 2003-12-09 2016-08-23 Dexcom, Inc. Signal processing for continuous analyte sensor
US8469886B2 (en) 2003-12-09 2013-06-25 Dexcom, Inc. Signal processing for continuous analyte sensor
US8005524B2 (en) 2003-12-09 2011-08-23 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100022855A1 (en) * 2003-12-09 2010-01-28 Dexcom, Inc. Signal processing for continuous analyte sensor
US8282549B2 (en) 2003-12-09 2012-10-09 Dexcom, Inc. Signal processing for continuous analyte sensor
US8233958B2 (en) 2003-12-09 2012-07-31 Dexcom, Inc. Signal processing for continuous analyte sensor
US9364173B2 (en) * 2003-12-09 2016-06-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US9351668B2 (en) 2003-12-09 2016-05-31 Dexcom, Inc. Signal processing for continuous analyte sensor
US8801610B2 (en) 2003-12-09 2014-08-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US8290561B2 (en) 2003-12-09 2012-10-16 Dexcom, Inc. Signal processing for continuous analyte sensor
US9750441B2 (en) 2003-12-09 2017-09-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US8257259B2 (en) 2003-12-09 2012-09-04 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100010331A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US10898113B2 (en) 2003-12-09 2021-01-26 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090299162A1 (en) * 2003-12-09 2009-12-03 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090036758A1 (en) * 2003-12-09 2009-02-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US9192328B2 (en) 2003-12-09 2015-11-24 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100179400A1 (en) * 2003-12-09 2010-07-15 Dexcom, Inc. Signal processing for continuous analyte sensor
US8216139B2 (en) 2003-12-09 2012-07-10 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043541A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US8374667B2 (en) 2003-12-09 2013-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090204341A1 (en) * 2003-12-09 2009-08-13 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090203981A1 (en) * 2003-12-09 2009-08-13 Dexcom, Inc. Signal processing for continuous analyte sensor
US8747315B2 (en) 2003-12-09 2014-06-10 Dexcom. Inc. Signal processing for continuous analyte sensor
US9107623B2 (en) 2003-12-09 2015-08-18 Dexcom, Inc. Signal processing for continuous analyte sensor
US8657745B2 (en) 2003-12-09 2014-02-25 Dexcom, Inc. Signal processing for continuous analyte sensor
US11638541B2 (en) 2003-12-09 2023-05-02 Dexconi, Inc. Signal processing for continuous analyte sensor
US20090062635A1 (en) * 2003-12-09 2009-03-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100049024A1 (en) * 2004-01-12 2010-02-25 Dexcom, Inc. Composite material for implantable device
US7976492B2 (en) 2004-02-26 2011-07-12 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US12102410B2 (en) 2004-02-26 2024-10-01 Dexcom, Inc Integrated medicament delivery device for use with continuous analyte sensor
US12115357B2 (en) 2004-02-26 2024-10-15 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US11246990B2 (en) 2004-02-26 2022-02-15 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8882741B2 (en) 2004-02-26 2014-11-11 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8920401B2 (en) 2004-02-26 2014-12-30 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8926585B2 (en) 2004-02-26 2015-01-06 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US10966609B2 (en) 2004-02-26 2021-04-06 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US9937293B2 (en) 2004-02-26 2018-04-10 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US9155843B2 (en) 2004-02-26 2015-10-13 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US10278580B2 (en) 2004-02-26 2019-05-07 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20080262469A1 (en) * 2004-02-26 2008-10-23 Dexcom. Inc. Integrated medicament delivery device for use with continuous analyte sensor
US10835672B2 (en) 2004-02-26 2020-11-17 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US9050413B2 (en) 2004-02-26 2015-06-09 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8721585B2 (en) 2004-02-26 2014-05-13 Dex Com, Inc. Integrated delivery device for continuous glucose sensor
US20100259543A1 (en) * 2004-03-15 2010-10-14 E-San Ltd. Medical Data Display
US20100114002A1 (en) * 2004-04-08 2010-05-06 O'mahony John J Method and apparatus for an extracorporeal control of blood glucose
US20070276209A1 (en) * 2004-04-30 2007-11-29 Fumiaki Emoto Blood-Sugar Level Measuring Device
US10327638B2 (en) 2004-05-03 2019-06-25 Dexcom, Inc. Transcutaneous analyte sensor
US9833143B2 (en) 2004-05-03 2017-12-05 Dexcom, Inc. Transcutaneous analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US20090030294A1 (en) * 2004-05-03 2009-01-29 Dexcom, Inc. Implantable analyte sensor
US20100041971A1 (en) * 2004-05-03 2010-02-18 Dexcom, Inc. Implantable analyte sensor
US7949381B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US10799158B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US10524703B2 (en) 2004-07-13 2020-01-07 Dexcom, Inc. Transcutaneous analyte sensor
US8457708B2 (en) 2004-07-13 2013-06-04 Dexcom, Inc. Transcutaneous analyte sensor
US8463350B2 (en) 2004-07-13 2013-06-11 Dexcom, Inc. Transcutaneous analyte sensor
US20080194938A1 (en) * 2004-07-13 2008-08-14 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US9814414B2 (en) 2004-07-13 2017-11-14 Dexcom, Inc. Transcutaneous analyte sensor
US8170803B2 (en) 2004-07-13 2012-05-01 Dexcom, Inc. Transcutaneous analyte sensor
US8475373B2 (en) 2004-07-13 2013-07-02 Dexcom, Inc. Transcutaneous analyte sensor
US10932700B2 (en) 2004-07-13 2021-03-02 Dexcom, Inc. Analyte sensor
US8229534B2 (en) 2004-07-13 2012-07-24 Dexcom, Inc. Transcutaneous analyte sensor
US8483791B2 (en) 2004-07-13 2013-07-09 Dexcom, Inc. Transcutaneous analyte sensor
US9833176B2 (en) 2004-07-13 2017-12-05 Dexcom, Inc. Transcutaneous analyte sensor
US20090216103A1 (en) * 2004-07-13 2009-08-27 Dexcom, Inc. Transcutaneous analyte sensor
US8231531B2 (en) * 2004-07-13 2012-07-31 Dexcom, Inc. Analyte sensor
US8515519B2 (en) 2004-07-13 2013-08-20 Dexcom, Inc. Transcutaneous analyte sensor
US8515516B2 (en) 2004-07-13 2013-08-20 Dexcom, Inc. Transcutaneous analyte sensor
US10918315B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US9610031B2 (en) 2004-07-13 2017-04-04 Dexcom, Inc. Transcutaneous analyte sensor
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8548551B2 (en) 2004-07-13 2013-10-01 Dexcom, Inc. Transcutaneous analyte sensor
US10980452B2 (en) 2004-07-13 2021-04-20 Dexcom, Inc. Analyte sensor
US10918314B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US20080214915A1 (en) * 2004-07-13 2008-09-04 Dexcom, Inc. Transcutaneous analyte sensor
US8565849B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US10993642B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US8571625B2 (en) 2004-07-13 2013-10-29 Dexcom, Inc. Transcutaneous analyte sensor
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918313B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US20110178378A1 (en) * 2004-07-13 2011-07-21 Dexcom, Inc. Transcutaneous analyte sensor
US10022078B2 (en) 2004-07-13 2018-07-17 Dexcom, Inc. Analyte sensor
US20070038044A1 (en) * 2004-07-13 2007-02-15 Dobbles J M Analyte sensor
US8615282B2 (en) 2004-07-13 2013-12-24 Dexcom, Inc. Analyte sensor
US10993641B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US20060142651A1 (en) * 2004-07-13 2006-06-29 Mark Brister Analyte sensor
US20060270923A1 (en) * 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US9078626B2 (en) 2004-07-13 2015-07-14 Dexcom, Inc. Transcutaneous analyte sensor
US20090076361A1 (en) * 2004-07-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US9775543B2 (en) 2004-07-13 2017-10-03 Dexcom, Inc. Transcutaneous analyte sensor
US10827956B2 (en) 2004-07-13 2020-11-10 Dexcom, Inc. Analyte sensor
US8663109B2 (en) 2004-07-13 2014-03-04 Dexcom, Inc. Transcutaneous analyte sensor
US10813576B2 (en) 2004-07-13 2020-10-27 Dexcom, Inc. Analyte sensor
US20090124879A1 (en) * 2004-07-13 2009-05-14 Dexcom, Inc. Transcutaneous analyte sensor
US10799159B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US9801572B2 (en) 2004-07-13 2017-10-31 Dexcom, Inc. Transcutaneous analyte sensor
US10314525B2 (en) 2004-07-13 2019-06-11 Dexcom, Inc. Analyte sensor
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US20070163880A1 (en) * 2004-07-13 2007-07-19 Dexcom, Inc. Analyte sensor
US20070173708A9 (en) * 2004-07-13 2007-07-26 Dobbles J M Analyte sensor
US8690775B2 (en) 2004-07-13 2014-04-08 Dexcom, Inc. Transcutaneous analyte sensor
US20080275313A1 (en) * 2004-07-13 2008-11-06 Dexcom, Inc. Transcutaneous analyte sensor
US8280475B2 (en) 2004-07-13 2012-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8721545B2 (en) 2004-07-13 2014-05-13 Dexcom, Inc. Transcutaneous analyte sensor
US8731630B2 (en) 2004-07-13 2014-05-20 Dexcom, Inc. Transcutaneous analyte sensor
US20100223022A1 (en) * 2004-07-13 2010-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US20100223013A1 (en) * 2004-07-13 2010-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US20100223023A1 (en) * 2004-07-13 2010-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US9060742B2 (en) 2004-07-13 2015-06-23 Dexcom, Inc. Transcutaneous analyte sensor
US20100191082A1 (en) * 2004-07-13 2010-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8750955B2 (en) * 2004-07-13 2014-06-10 Dexcom, Inc. Analyte sensor
US20100185069A1 (en) * 2004-07-13 2010-07-22 Dexcom, Inc. Transcutaneous analyte sensor
US10722152B2 (en) 2004-07-13 2020-07-28 Dexcom, Inc. Analyte sensor
US9055901B2 (en) 2004-07-13 2015-06-16 Dexcom, Inc. Transcutaneous analyte sensor
US20100174163A1 (en) * 2004-07-13 2010-07-08 Dexcom, Inc. Transcutaneous analyte sensor
US11026605B1 (en) 2004-07-13 2021-06-08 Dexcom, Inc. Analyte sensor
US20100174158A1 (en) * 2004-07-13 2010-07-08 Dexcom, Inc. Transcutaneous analyte sensor
US9044199B2 (en) 2004-07-13 2015-06-02 Dexcom, Inc. Transcutaneous analyte sensor
US11045120B2 (en) 2004-07-13 2021-06-29 Dexcom, Inc. Analyte sensor
US8290560B2 (en) 2004-07-13 2012-10-16 Dexcom, Inc. Transcutaneous analyte sensor
US20060020190A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US8792953B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8792954B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US11064917B2 (en) 2004-07-13 2021-07-20 Dexcom, Inc. Analyte sensor
US10709362B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US20100081908A1 (en) * 2004-07-13 2010-04-01 Dexcom, Inc. Analyte sensor
US20060036139A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US8801611B2 (en) 2004-07-13 2014-08-12 Dexcom, Inc. Transcutaneous analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US10709363B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US8313434B2 (en) 2004-07-13 2012-11-20 Dexcom, Inc. Analyte sensor inserter system
US8812072B2 (en) 2004-07-13 2014-08-19 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20060183984A1 (en) * 2004-07-13 2006-08-17 Dobbles J M Analyte sensor
US20090156919A1 (en) * 2004-07-13 2009-06-18 Dexcom, Inc. Transcutaneous analyte sensor
US20060036142A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US8825127B2 (en) 2004-07-13 2014-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US20090163790A1 (en) * 2004-07-13 2009-06-25 Dexcom, Inc. Transcutaneous analyte sensor
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) * 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
US20080242961A1 (en) * 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8858434B2 (en) 2004-07-13 2014-10-14 Dexcom, Inc. Transcutaneous analyte sensor
US9668677B2 (en) 2004-07-13 2017-06-06 Dexcom, Inc. Analyte sensor
US8390455B2 (en) 2005-02-08 2013-03-05 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8542122B2 (en) 2005-02-08 2013-09-24 Abbott Diabetes Care Inc. Glucose measurement device and methods using RFID
US8115635B2 (en) 2005-02-08 2012-02-14 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8223021B2 (en) 2005-02-08 2012-07-17 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8358210B2 (en) 2005-02-08 2013-01-22 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8611978B2 (en) 2005-03-10 2013-12-17 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20060258929A1 (en) * 2005-03-10 2006-11-16 Goode Paul V Jr System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9314196B2 (en) 2005-03-10 2016-04-19 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610102B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. Transcutaneous analyte sensor
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10624539B2 (en) 2005-03-10 2020-04-21 Dexcom, Inc. Transcutaneous analyte sensor
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9220449B2 (en) 2005-03-10 2015-12-29 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9918668B2 (en) 2005-03-10 2018-03-20 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8560037B2 (en) 2005-03-10 2013-10-15 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20100168545A1 (en) * 2005-03-10 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20100168546A1 (en) * 2005-03-10 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20100179402A1 (en) * 2005-03-10 2010-07-15 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8579816B2 (en) 2005-03-10 2013-11-12 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9078608B2 (en) 2005-03-10 2015-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610103B2 (en) 2005-06-21 2020-04-07 Dexcom, Inc. Transcutaneous analyte sensor
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor
US10709332B2 (en) 2005-06-21 2020-07-14 Dexcom, Inc. Transcutaneous analyte sensor
US10842427B2 (en) 2005-09-30 2020-11-24 Intuity Medical, Inc. Body fluid sampling arrangements
US9839384B2 (en) 2005-09-30 2017-12-12 Intuity Medical, Inc. Body fluid sampling arrangements
US10441205B2 (en) 2005-09-30 2019-10-15 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20090043240A1 (en) * 2005-11-15 2009-02-12 Mark Ries Robinson Method and apparatus for blood transport using a pressure controller in measurement of blood characteristics
US20070225675A1 (en) * 2005-11-15 2007-09-27 Mark Ries Robinson Blood Analyte Determinations
US20110282327A1 (en) * 2005-12-05 2011-11-17 Echo Therapeutics, Inc. System and method for continuous non-invasive glucose monitoring
US11355238B2 (en) * 2006-01-05 2022-06-07 University Of Virginia Patent Foundation Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US10265000B2 (en) 2006-01-17 2019-04-23 Dexcom, Inc. Low oxygen in vivo analyte sensor
US11191458B2 (en) 2006-01-17 2021-12-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US11596332B2 (en) 2006-01-17 2023-03-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20070197889A1 (en) * 2006-02-22 2007-08-23 Mark Brister Analyte sensor
US9724028B2 (en) 2006-02-22 2017-08-08 Dexcom, Inc. Analyte sensor
US20100168535A1 (en) * 2006-04-12 2010-07-01 Mark Ries Robinson Methods and apparatuses related to blood analyte measurement system
US20070255347A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Inhibition of stimulation notification
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US20080014913A1 (en) * 2006-07-12 2008-01-17 Jason Balan Cellular mobile modbus data collection
US20080027290A1 (en) * 2006-07-26 2008-01-31 Terry Keith Bryant Base station for retrieving data from and programming a medical device
WO2008014320A3 (en) * 2006-07-26 2008-12-11 Carson Valley Res Llc Base station for retrieving data from and programming a medical device
WO2008014320A2 (en) * 2006-07-26 2008-01-31 Carson Valley Research, Llc Base station for retrieving data from and programming a medical device
US11432772B2 (en) 2006-08-02 2022-09-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9833181B2 (en) 2006-08-09 2017-12-05 Abbot Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US10278630B2 (en) 2006-08-09 2019-05-07 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US11864894B2 (en) 2006-08-09 2024-01-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US10342469B2 (en) 2006-10-02 2019-07-09 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US20080108942A1 (en) * 2006-10-04 2008-05-08 Dexcom, Inc. Analyte sensor
US8911367B2 (en) 2006-10-04 2014-12-16 Dexcom, Inc. Analyte sensor
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US20080214918A1 (en) * 2006-10-04 2008-09-04 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9504413B2 (en) 2006-10-04 2016-11-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080200791A1 (en) * 2006-10-04 2008-08-21 Dexcom, Inc. Analyte sensor
US20090131776A1 (en) * 2006-10-04 2009-05-21 Dexcom, Inc. Analyte sensor
US20080200789A1 (en) * 2006-10-04 2008-08-21 Dexcom, Inc. Analyte sensor
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US20090131769A1 (en) * 2006-10-04 2009-05-21 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US20090131777A1 (en) * 2006-10-04 2009-05-21 Dexcom, Inc. Analyte sensor
US20090137887A1 (en) * 2006-10-04 2009-05-28 Dexcom, Inc. Analyte sensor
US10349873B2 (en) 2006-10-04 2019-07-16 Dexcom, Inc. Analyte sensor
US10136844B2 (en) 2006-10-04 2018-11-27 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20090287074A1 (en) * 2006-10-04 2009-11-19 Dexcom, Inc. Analyte sensor
US20100081910A1 (en) * 2006-10-04 2010-04-01 Dexcom, Inc. Analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US7775975B2 (en) 2006-10-04 2010-08-17 Dexcom, Inc. Analyte sensor
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11399745B2 (en) 2006-10-04 2022-08-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080086042A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Analyte sensor
US8562528B2 (en) 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US20080083617A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8275438B2 (en) 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US8478377B2 (en) 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
US8425416B2 (en) 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
US8449464B2 (en) 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US20090018424A1 (en) * 2006-10-04 2009-01-15 Dexcom, Inc. Analyte sensor
US11382539B2 (en) 2006-10-04 2022-07-12 Dexcom, Inc. Analyte sensor
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US11217339B2 (en) 2006-10-17 2022-01-04 Tandem Diabetes Care, Inc. Food database for insulin pump
US8821433B2 (en) 2006-10-17 2014-09-02 Tandem Diabetes Care, Inc. Insulin pump having basal rate testing features
US20080092638A1 (en) * 2006-10-19 2008-04-24 Bayer Healthcare Llc Wireless analyte monitoring system
US7742807B1 (en) * 2006-11-07 2010-06-22 Pacesetter, Inc. Musical representation of cardiac markers
US20080139910A1 (en) * 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
US20120227737A1 (en) * 2006-12-06 2012-09-13 Medtronic Minimed, Inc. Analyte sensor and method of using the same
US8092386B1 (en) * 2006-12-22 2012-01-10 Pacesetter, Inc. Method and implantable system for blood-glucose concentration monitoring
US10617823B2 (en) 2007-02-15 2020-04-14 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080220403A1 (en) * 2007-02-16 2008-09-11 Ohio University System and method for managing diabetes
US11291763B2 (en) 2007-03-13 2022-04-05 Tandem Diabetes Care, Inc. Basal rate testing using frequent blood glucose input
EP2184694A3 (de) * 2007-03-20 2016-05-11 Lifescan, Inc. Kommunikationsmedium für die Diabetes-Verwaltung
US20080255437A1 (en) * 2007-04-14 2008-10-16 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US10111608B2 (en) * 2007-04-14 2018-10-30 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US20150208960A1 (en) * 2007-04-14 2015-07-30 Abbott Diabetes Care Inc. Method and Apparatus for Providing Data Processing and Control in Medical Communication System
US10349877B2 (en) * 2007-04-14 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US11039767B2 (en) 2007-04-14 2021-06-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10634662B2 (en) 2007-05-14 2020-04-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10463310B2 (en) 2007-05-14 2019-11-05 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11125592B2 (en) 2007-05-14 2021-09-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10143409B2 (en) 2007-05-14 2018-12-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10261069B2 (en) 2007-05-14 2019-04-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11300561B2 (en) 2007-05-14 2022-04-12 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US10976304B2 (en) 2007-05-14 2021-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11828748B2 (en) 2007-05-14 2023-11-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11119090B2 (en) 2007-05-14 2021-09-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10653344B2 (en) 2007-05-14 2020-05-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10991456B2 (en) 2007-05-14 2021-04-27 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US11076785B2 (en) 2007-05-14 2021-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10031002B2 (en) 2007-05-14 2018-07-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10119956B2 (en) 2007-05-14 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10943687B2 (en) 2007-05-24 2021-03-09 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US10357607B2 (en) 2007-05-24 2019-07-23 Tandem Diabetes Care, Inc. Correction factor testing using frequent blood glucose input
US11257580B2 (en) 2007-05-24 2022-02-22 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US11848089B2 (en) 2007-05-24 2023-12-19 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US9474856B2 (en) 2007-05-24 2016-10-25 Tandem Diabetes Care, Inc. Expert system for infusion pump therapy
US11576594B2 (en) 2007-05-30 2023-02-14 Tandem Diabetes Care, Inc. Insulin pump based expert system
US11298053B2 (en) 2007-05-30 2022-04-12 Tandem Diabetes Care, Inc. Insulin pump based expert system
US11986292B2 (en) 2007-05-30 2024-05-21 Tandem Diabetes Care, Inc. Insulin pump based expert system
US9833177B2 (en) 2007-05-30 2017-12-05 Tandem Diabetes Care, Inc. Insulin pump based expert system
US8562558B2 (en) 2007-06-08 2013-10-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20080306435A1 (en) * 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US9741139B2 (en) 2007-06-08 2017-08-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US10403012B2 (en) 2007-06-08 2019-09-03 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US11373347B2 (en) 2007-06-08 2022-06-28 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US11678821B2 (en) 2007-06-29 2023-06-20 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US10856785B2 (en) 2007-06-29 2020-12-08 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US20090036753A1 (en) * 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
US20090048535A1 (en) * 2007-08-13 2009-02-19 Mark Ries Robinson Detecting Cross-contamination in Blood Measurements with a Multilumen Catheter
US20090054754A1 (en) * 2007-08-21 2009-02-26 Mcmahon Dave Clinician-controlled semi-automated medication management
US12016648B2 (en) 2007-09-13 2024-06-25 Dexcom, Inc. Transcutaneous analyte sensor
US9451910B2 (en) 2007-09-13 2016-09-27 Dexcom, Inc. Transcutaneous analyte sensor
US9668682B2 (en) 2007-09-13 2017-06-06 Dexcom, Inc. Transcutaneous analyte sensor
US11672422B2 (en) 2007-09-13 2023-06-13 Dexcom, Inc. Transcutaneous analyte sensor
US20090088615A1 (en) * 2007-10-01 2009-04-02 Mark Ries Robinson Indwelling Fiber Optic Probe for Blood Glucose Measurements
US11744943B2 (en) 2007-10-09 2023-09-05 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US11160926B1 (en) 2007-10-09 2021-11-02 Dexcom, Inc. Pre-connected analyte sensors
US10653835B2 (en) 2007-10-09 2020-05-19 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US20090192751A1 (en) * 2007-10-25 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US10182751B2 (en) 2007-10-25 2019-01-22 Dexcom, Inc. Systems and methods for processing sensor data
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US9717449B2 (en) 2007-10-25 2017-08-01 Dexcom, Inc. Systems and methods for processing sensor data
US11272869B2 (en) 2007-10-25 2022-03-15 Dexcom, Inc. Systems and methods for processing sensor data
US20090156975A1 (en) * 2007-11-30 2009-06-18 Mark Ries Robinson Robust System and Methods for Blood Access
US11450411B2 (en) 2007-12-10 2022-09-20 Ascensia Diabetes Care Holdings Ag Interface for a health measurement and monitoring system
US20150223763A1 (en) * 2007-12-10 2015-08-13 Bayer Healthcare Llc Interface for a health measurement and monitoring system
US10548537B2 (en) * 2007-12-10 2020-02-04 Ascensia Diabetes Care Holdings Ag Interface for a health measurement and monitoring system
US8318096B2 (en) 2007-12-12 2012-11-27 Panasonic Corporation Biological sample measurement apparatus
US20100035334A1 (en) * 2007-12-12 2010-02-11 Eiji Okuda Biological sample measurement apparatus
US20120302855A1 (en) * 2007-12-17 2012-11-29 Dexcom, Inc. Systems and methods for processing sensor data
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US9149234B2 (en) * 2007-12-17 2015-10-06 Dexcom, Inc. Systems and methods for processing sensor data
US9149233B2 (en) 2007-12-17 2015-10-06 Dexcom, Inc. Systems and methods for processing sensor data
US20090192366A1 (en) * 2007-12-17 2009-07-30 Dexcom, Inc Systems and methods for processing sensor data
US20090192722A1 (en) * 2007-12-17 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US9339238B2 (en) 2007-12-17 2016-05-17 Dexcom, Inc. Systems and methods for processing sensor data
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
US10506982B2 (en) 2007-12-17 2019-12-17 Dexcom, Inc. Systems and methods for processing sensor data
US11342058B2 (en) 2007-12-17 2022-05-24 Dexcom, Inc. Systems and methods for processing sensor data
US10827980B2 (en) 2007-12-17 2020-11-10 Dexcom, Inc. Systems and methods for processing sensor data
US9901307B2 (en) 2007-12-17 2018-02-27 Dexcom, Inc. Systems and methods for processing sensor data
US11302433B2 (en) 2008-01-07 2022-04-12 Tandem Diabetes Care, Inc. Diabetes therapy coaching
US10052049B2 (en) * 2008-01-07 2018-08-21 Tandem Diabetes Care, Inc. Infusion pump with blood glucose alert delay
US20140350371A1 (en) * 2008-01-07 2014-11-27 Tandem Diabetes Care, Inc. Infusion pump with blood glucose alert delay
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8591455B2 (en) 2008-02-21 2013-11-26 Dexcom, Inc. Systems and methods for customizing delivery of sensor data
US11102306B2 (en) 2008-02-21 2021-08-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US20090242425A1 (en) * 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US10602968B2 (en) 2008-03-25 2020-03-31 Dexcom, Inc. Analyte sensor
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US11896374B2 (en) 2008-03-25 2024-02-13 Dexcom, Inc. Analyte sensor
US11779248B2 (en) 2008-03-28 2023-10-10 Abbott Diabetes Care Inc. Analyte sensor calibration management
US10463288B2 (en) 2008-03-28 2019-11-05 Abbott Diabetes Care Inc. Analyte sensor calibration management
US11045125B2 (en) 2008-05-30 2021-06-29 Intuity Medical, Inc. Body fluid sampling device-sampling site interface
US10327682B2 (en) 2008-05-30 2019-06-25 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US11735295B2 (en) 2008-05-30 2023-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US11986293B2 (en) 2008-06-06 2024-05-21 Intuity Medical, Inc. Medical diagnostic devices and methods
US11399744B2 (en) 2008-06-06 2022-08-02 Intuity Medical, Inc. Detection meter and mode of operation
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US11553860B2 (en) 2008-06-06 2023-01-17 Intuity Medical, Inc. Medical diagnostic devices and methods
USRE47353E1 (en) * 2008-07-29 2019-04-16 Masimo Corporation Alarm suspend system
USRE47249E1 (en) * 2008-07-29 2019-02-19 Masimo Corporation Alarm suspend system
USRE47244E1 (en) * 2008-07-29 2019-02-19 Masimo Corporation Alarm suspend system
US9339222B2 (en) 2008-09-19 2016-05-17 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US8560039B2 (en) 2008-09-19 2013-10-15 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US11918354B2 (en) 2008-09-19 2024-03-05 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10561352B2 (en) 2008-09-19 2020-02-18 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US20100076283A1 (en) * 2008-09-19 2010-03-25 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10028684B2 (en) 2008-09-19 2018-07-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10028683B2 (en) 2008-09-19 2018-07-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10045739B2 (en) 2008-09-30 2018-08-14 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US20100094114A1 (en) * 2008-10-09 2010-04-15 Mark Ries Robinson Use of multiple calibration solutions with an analyte sensor with use in an automated blood access system
US20150320933A1 (en) * 2008-10-15 2015-11-12 Bigfoot Biomedical, Inc. Infusion Pump System and Methods
US20180093039A1 (en) * 2008-10-15 2018-04-05 Bigfoot Biomedical, Inc. Infusion Pump System and Methods
US9844627B2 (en) * 2008-10-15 2017-12-19 Bigfoot Biomedical, Inc. Infusion pump system and methods
US11957874B2 (en) 2008-10-15 2024-04-16 Insulet Corporation Infusion pump system and methods
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10675405B2 (en) 2009-03-27 2020-06-09 Dexcom, Inc. Methods and systems for simulating glucose response to simulated actions
US10537678B2 (en) 2009-03-27 2020-01-21 Dexcom, Inc. Methods and systems for promoting glucose management
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US10610642B2 (en) 2009-03-27 2020-04-07 Dexcom, Inc. Methods and systems for promoting glucose management
US9282895B2 (en) 2009-03-30 2016-03-15 Pacesetter, Inc. Method and implantable system for blood-glucose concentration monitoring using parallel methodologies
US20170035969A1 (en) * 2009-05-22 2017-02-09 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
US20200405224A1 (en) * 2009-06-17 2020-12-31 Medtronic Minimed, Inc. Closed-loop glucose and/or insulin control system
US10959639B2 (en) * 2009-06-26 2021-03-30 T&W Engineering A/S EEG monitoring apparatus and method for presenting messages therein
US20120165695A1 (en) * 2009-06-26 2012-06-28 Widex A/S Eeg monitoring apparatus and method for presenting messages therein
US20100332142A1 (en) * 2009-06-30 2010-12-30 Lifescan,Inc. Analyte testing method and device for calculating basal insulin therapy
US20100332445A1 (en) * 2009-06-30 2010-12-30 Lifescan, Inc. Analyte testing method and system
US20100331654A1 (en) * 2009-06-30 2010-12-30 Lifescan Scotland Ltd. Systems for diabetes management and methods
US8688386B2 (en) 2009-06-30 2014-04-01 Lifescan, Inc. Analyte testing method and device for calculating basal insulin therapy
US9320466B2 (en) 2009-07-02 2016-04-26 Dexcom, Inc. Analyte sensor
US20110028816A1 (en) * 2009-07-02 2011-02-03 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US9517025B2 (en) 2009-07-02 2016-12-13 Dexcom, Inc. Analyte sensor with increased reference capacity
US9907497B2 (en) 2009-07-02 2018-03-06 Dexcom, Inc. Analyte sensor
US12011266B2 (en) 2009-07-02 2024-06-18 Dexcom, Inc. Analyte sensor
US9237864B2 (en) 2009-07-02 2016-01-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US9131885B2 (en) 2009-07-02 2015-09-15 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US20110028815A1 (en) * 2009-07-02 2011-02-03 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US20110027127A1 (en) * 2009-07-02 2011-02-03 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US20110024307A1 (en) * 2009-07-02 2011-02-03 Dexcom, Inc. Analyte sensor
US10420494B2 (en) 2009-07-02 2019-09-24 Dexcom, Inc. Analyte sensor
US9351677B2 (en) 2009-07-02 2016-05-31 Dexcom, Inc. Analyte sensor with increased reference capacity
US8828201B2 (en) 2009-07-02 2014-09-09 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US11559229B2 (en) 2009-07-02 2023-01-24 Dexcom, Inc. Analyte sensor
US10470691B2 (en) 2009-07-02 2019-11-12 Dexcom, Inc. Analyte sensor with increased reference capacity
US9763608B2 (en) 2009-07-02 2017-09-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US10827954B2 (en) 2009-07-23 2020-11-10 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US8287495B2 (en) 2009-07-30 2012-10-16 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9211377B2 (en) 2009-07-30 2015-12-15 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US11285263B2 (en) 2009-07-30 2022-03-29 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US12042627B2 (en) 2009-07-30 2024-07-23 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US11135362B2 (en) 2009-07-30 2021-10-05 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US8758323B2 (en) 2009-07-30 2014-06-24 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8298184B2 (en) 2009-07-30 2012-10-30 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8926561B2 (en) 2009-07-30 2015-01-06 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US10660554B2 (en) * 2009-07-31 2020-05-26 Abbott Diabetes Care Inc. Methods and devices for analyte monitoring calibration
US11234625B2 (en) 2009-07-31 2022-02-01 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US20180344220A1 (en) * 2009-07-31 2018-12-06 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US9936910B2 (en) * 2009-07-31 2018-04-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US20140236536A1 (en) * 2009-07-31 2014-08-21 Abbott Diabetes Care Inc. Method and Apparatus for Providing Analyte Monitoring and Therapy Management System Accuracy
US10918342B1 (en) 2009-08-31 2021-02-16 Abbott Diabetes Care Inc. Displays for a medical device
US10772572B2 (en) 2009-08-31 2020-09-15 Abbott Diabetes Care Inc. Displays for a medical device
US11202586B2 (en) 2009-08-31 2021-12-21 Abbott Diabetes Care Inc. Displays for a medical device
US10881355B2 (en) 2009-08-31 2021-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US11730429B2 (en) 2009-08-31 2023-08-22 Abbott Diabetes Care Inc. Displays for a medical device
US11241175B2 (en) 2009-08-31 2022-02-08 Abbott Diabetes Care Inc. Displays for a medical device
US8974387B2 (en) 2009-09-29 2015-03-10 Lifescan Scotland Limited Analyte testing method and device for diabetes management
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US20110077493A1 (en) * 2009-09-29 2011-03-31 Lifescan Scotland Ltd. Analyte testing method and device for diabetes mangement
US20120220847A1 (en) * 2009-11-04 2012-08-30 Aimedics Pty Ltd Alarm systems using monitored physiological data and trend difference methods
US11933789B2 (en) 2009-11-30 2024-03-19 Intuity Medical, Inc. Calibration material delivery devices and methods
US9897610B2 (en) 2009-11-30 2018-02-20 Intuity Medical, Inc. Calibration material delivery devices and methods
US11002743B2 (en) 2009-11-30 2021-05-11 Intuity Medical, Inc. Calibration material delivery devices and methods
US10016559B2 (en) 2009-12-04 2018-07-10 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US11090432B2 (en) 2009-12-04 2021-08-17 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US20110152634A1 (en) * 2009-12-17 2011-06-23 Jeff Thew Measuring Human Biological Fluid Levels
US20110152642A1 (en) * 2009-12-18 2011-06-23 Mak Ries Robinson Detection of bubbles during hemodynamic monitoring when performing automated measurement of blood constituents
US8323194B2 (en) 2009-12-18 2012-12-04 Inlight Solutions, Inc. Detection of bubbles during hemodynamic monitoring when performing automated measurement of blood constituents
US20110205064A1 (en) * 2010-02-25 2011-08-25 Lifescan Scotland Ltd. Analyte testing method and system with high and low blood glucose trends notification
US9563743B2 (en) 2010-02-25 2017-02-07 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
USRE47882E1 (en) 2010-03-01 2020-03-03 Masimo Corporation Adaptive alarm system
USRE49007E1 (en) 2010-03-01 2022-04-05 Masimo Corporation Adaptive alarm system
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
EP2593891B1 (de) * 2010-07-16 2019-10-30 Meierhofer Medizintechnik GmbH Verfahren zur überwachung der medizinischen parameter eines patienten
DE102010027486A1 (de) * 2010-07-16 2012-04-12 Löser Medizintechnik GmbH Verfahren zur Überwachung des medizinischen Zustandes eines Patienten
US11051734B2 (en) 2011-08-03 2021-07-06 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11382544B2 (en) 2011-08-03 2022-07-12 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11672452B2 (en) 2011-08-03 2023-06-13 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US10939859B2 (en) 2011-11-23 2021-03-09 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10258736B2 (en) 2012-05-17 2019-04-16 Tandem Diabetes Care, Inc. Systems including vial adapter for fluid transfer
US11676694B2 (en) 2012-06-07 2023-06-13 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US20150201846A1 (en) * 2012-07-24 2015-07-23 Medbright Medical Solutions Ltd Device and method for providing information indicative of a stress situation in a human
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10345291B2 (en) 2012-08-30 2019-07-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10656139B2 (en) 2012-08-30 2020-05-19 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10942164B2 (en) 2012-08-30 2021-03-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US11896371B2 (en) 2012-09-26 2024-02-13 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US11026640B1 (en) 2012-10-30 2021-06-08 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US11690577B2 (en) 2012-10-30 2023-07-04 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US10143426B2 (en) 2012-10-30 2018-12-04 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US9119528B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for providing sensitive and specific alarms
US11006903B2 (en) 2012-10-30 2021-05-18 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US10555705B2 (en) 2012-10-30 2020-02-11 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US10702215B2 (en) 2012-10-30 2020-07-07 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US9119529B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US9655565B2 (en) 2012-10-30 2017-05-23 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US9995779B2 (en) 2012-11-01 2018-06-12 Terumo Kabushiki Kaisha Sensing device and sensing method
US11213204B2 (en) 2012-12-31 2022-01-04 Dexcom, Inc. Remote monitoring of analyte measurements
US12102454B2 (en) 2012-12-31 2024-10-01 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US11850020B2 (en) 2012-12-31 2023-12-26 Dexcom, Inc. Remote monitoring of analyte measurements
US11109757B2 (en) 2012-12-31 2021-09-07 Dexcom, Inc. Remote monitoring of analyte measurements
US10019554B2 (en) 2012-12-31 2018-07-10 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose
US11744463B2 (en) 2012-12-31 2023-09-05 Dexcom, Inc. Remote monitoring of analyte measurements
US11160452B2 (en) 2012-12-31 2021-11-02 Dexcom, Inc. Remote monitoring of analyte measurements
US11382508B2 (en) 2012-12-31 2022-07-12 Dexcom, Inc. Remote monitoring of analyte measurements
US11331051B2 (en) 2012-12-31 2022-05-17 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
US11607492B2 (en) 2013-03-13 2023-03-21 Tandem Diabetes Care, Inc. System and method for integration and display of data of insulin pumps and continuous glucose monitoring
US9962486B2 (en) 2013-03-14 2018-05-08 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US10010291B2 (en) 2013-03-15 2018-07-03 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
USD1030780S1 (en) 2013-03-15 2024-06-11 Abbott Diabetes Care Inc. Display screen or portion thereof with graphical user interface for continuous glucose monitoring
US11963801B2 (en) 2013-03-15 2024-04-23 Abbott Diabetes Care Inc. Systems and methods for use of insulin information for meal indication
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US11304664B2 (en) 2013-03-15 2022-04-19 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback
WO2014205412A1 (en) * 2013-06-21 2014-12-24 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US9867937B2 (en) 2013-09-06 2018-01-16 Tandem Diabetes Care, Inc. System and method for mitigating risk in automated medicament dosing
US10864322B2 (en) 2013-09-06 2020-12-15 Tandem Diabetes Care, Inc. System and method for mitigating risk in automated medicament dosing
US20150141763A1 (en) * 2013-11-18 2015-05-21 Honeywell International Inc. Non-invasive blood glucose concentration sensing using light modulation
US10007240B2 (en) * 2014-08-05 2018-06-26 Siemens Industry, Inc. Enhanced alarming with BACnet objects
CN106663358A (zh) * 2014-08-05 2017-05-10 西门子工业公司 利用BACnet对象的增强报警
US20160041537A1 (en) * 2014-08-05 2016-02-11 Siemens Industry, Inc. Enhanced alarming with bacnet objects
CN113870522A (zh) * 2014-08-05 2021-12-31 西门子工业公司 利用BACnet对象的增强报警
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US10932672B2 (en) * 2015-12-28 2021-03-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US11399721B2 (en) 2015-12-28 2022-08-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US11638781B2 (en) 2015-12-29 2023-05-02 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10737025B2 (en) * 2016-05-02 2020-08-11 Dexcom, Inc. System and method for providing alerts optimized for a user
US10052073B2 (en) * 2016-05-02 2018-08-21 Dexcom, Inc. System and method for providing alerts optimized for a user
US11837348B2 (en) 2016-05-02 2023-12-05 Dexcom, Inc. System and method for providing alerts optimized for a user
US20180326150A1 (en) * 2016-05-02 2018-11-15 Dexcom, Inc. System and method for providing alerts optimized for a user
US10328204B2 (en) 2016-05-02 2019-06-25 Dexcom, Inc. System and method for providing alerts optimized for a user
US9974903B1 (en) 2016-05-02 2018-05-22 Dexcom, Inc. System and method for providing alerts optimized for a user
US20170347971A1 (en) * 2016-05-02 2017-12-07 Dexcom, Inc. System and method for providing alerts optimized for a user
US10406287B2 (en) * 2016-05-02 2019-09-10 Dexcom, Inc. System and method for providing alerts optimized for a user
US11450421B2 (en) * 2016-05-02 2022-09-20 Dexcom, Inc. System and method for providing alerts optimized for a user
US20180103881A1 (en) * 2016-10-19 2018-04-19 Samsung Electronics Co., Ltd. Electronic apparatus and method for providing blood sugar care service
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11382540B2 (en) 2017-10-24 2022-07-12 Dexcom, Inc. Pre-connected analyte sensors
US11943876B2 (en) 2017-10-24 2024-03-26 Dexcom, Inc. Pre-connected analyte sensors
US11706876B2 (en) 2017-10-24 2023-07-18 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11883163B1 (en) * 2018-01-17 2024-01-30 Verily Life Sciences Llc Investigation of glycemic events in blood glucose
US11766194B2 (en) 2018-02-09 2023-09-26 Dexcom, Inc. System and method for decision support
US11723560B2 (en) 2018-02-09 2023-08-15 Dexcom, Inc. System and method for decision support
EP3764956B1 (de) 2018-03-15 2022-05-11 Coloplast A/S Verfahren zur verwaltung der resttragezeit einer stomavorrichtung und zugehörige zubehörgeräte
US11224693B2 (en) 2018-10-10 2022-01-18 Tandem Diabetes Care, Inc. System and method for switching between medicament delivery control algorithms
US11665238B2 (en) * 2019-03-29 2023-05-30 Bionime Corporation Method and system for data transmission between a sensor device and an electronic device
US20200314182A1 (en) * 2019-03-29 2020-10-01 Bionime Corporation Method and system for data transmission between a sensor device and an electronic device
US12059268B1 (en) 2019-04-30 2024-08-13 Verily Life Sciences Llc Managing meal excursions in blood glucose data
US11312298B2 (en) * 2020-01-30 2022-04-26 International Business Machines Corporation Modulating attention of responsible parties to predicted dangers of self-driving cars
CN112017778A (zh) * 2020-08-06 2020-12-01 东北大学 一种面向临床的多层级血糖异常预警方法

Also Published As

Publication number Publication date
DK1703839T3 (da) 2012-05-29
EP1703839A2 (de) 2006-09-27
EP1703839B1 (de) 2012-02-08
CA2550855C (en) 2013-03-26
US20070232880A1 (en) 2007-10-04
JP2007516783A (ja) 2007-06-28
WO2005065538A2 (en) 2005-07-21
US8961416B2 (en) 2015-02-24
CA2550855A1 (en) 2005-07-21
WO2005065538A3 (en) 2005-11-17
ATE544394T1 (de) 2012-02-15

Similar Documents

Publication Publication Date Title
US8961416B2 (en) System for monitoring physiological characteristics
US7022072B2 (en) System for monitoring physiological characteristics
US7399277B2 (en) System for monitoring physiological characteristics
US10080529B2 (en) System for monitoring physiological characteristics
EP1759201B1 (de) System zur überwachung physiologischer eigenschaften gemäss dem biologischen zustand des anwenders
US20080255438A1 (en) System for monitoring physiological characteristics
US20210145371A1 (en) Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
WO2007101260A2 (en) Smart messages and alerts for an infusion delivery and management system
CA2567711C (en) System for monitoring physiological characteristics

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIDDIQUI, UZAIR;PATEL HIMANSHU P.;MASTROTOTARO, JOHN J.;AND OTHERS;REEL/FRAME:015238/0001;SIGNING DATES FROM 20040602 TO 20041006

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION